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Abstract 
Biomaterials can be used in a wide variety of medical applications owing to their breadth of 
characteristics that can be imparted by varying their chemical structures. Butyl rubber (IIR), 
which is a copolymer of isobutylene (IB) and small percentages of isoprene (IP), is 
particularly attractive as a biomaterial because of its elastomeric mechanical properties, 
biocompatibility, impermeability and high damping characteristics. IIR is typically 
vulcanized through chemical-based crosslinking mechanisms. However, these methods are 
not acceptable for biological applications. This thesis focuses on the synthesis of IIR-
polyester graft copolymers by grafting biodegradable and biocompatible polyesters including 
poly(caprolactone) (PCL) and poly(D,L-lactide) (PDLLA) to the IIR backbone, and on the 
study of their properties. These graft copolymers were synthesized by the grafting of amine-
terminated polyesters on a modified IIR backbone having activated carbonate moieties. The 
resulting copolymers with varying polyester content were characterized by a wide range of 
chemical techniques including nuclear magnetic resonance and infrared spectroscopic 
methods as well as size exclusion chromatography. IIR-polyester copolymers displayed an 
increase in Young’s modulus (E) and ultimate tensile strength (UTS) relative to IIR, while 
maintaining cell-biomaterial interactions and non-toxicity. Despite significant polyester 
content, the copolymers did not exhibit any significant degradation, even in 5 M NaOH at 
37°C. Overall, this study reveals how the properties of IIR can be readily tuned through the 
preparation of graft copolymers and provides a comprehensive evaluation of these properties 
for their further study in biomedical applications. 
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Chapter 1 
1 Introduction 
1.1 Polymers and their Importance as Biomaterials 
Biomaterials possess the ability to perform with an appropriate host response in specific 
applications.
1
 They are used extensively in a wide variety of applications, ranging from 
cardiovascular, dental and neural implants to orthopaedic prosthetics and drug delivery 
systems. Biomaterials have always been important as vehicles for the treatment of 
disease, thereby constantly improving health care. Early examples dating back thousands 
of years ago are metals and wood for teeth replacement and glass for eyeball prosthetics. 
However, the discovery of synthetic polymers such as poly(methacrylates) and 
poly(urethanes) led to a much broader range of application possibilities. Moreover, 
naturally occurring materials such as collagen are also being developed for better 
applicability in biological systems. 
 Although biomaterials perhaps play a role in the lives of many individuals, there 
are several difficulties involved with their use. The main issues stem from deficiencies in 
understanding physical, chemical and biological responses that a given biomaterial may 
elicit in biological systems, as well as the lack of proper performance in a specific 
application.
2
 Since many biomaterials were not originally designed to be used in a 
clinical setting, taking off-the-shelf products has proved to be problematic.
3
 Examples of 
such consist of dialysis tubing derived from cellulose acetate, Dacron for synthesis of 
vascular grafts and poly(urethane) for the fabrication of artificial hearts. The 
aforementioned applications were unsuccessful as cellulose acetate caused platelet 
activation, Dacron grafts were limited to large-diameter vessel applications and 
poly(urethane) did not supply sufficient blood-material interactions, respectively.
4
 
 In order to reduce issues related to using materials in applications for which they 
were not specifically designed, research has been directed toward modifying chemical 
structures to improve their mechanical properties, degradability and biocompatibility.
5
 
Modern biomaterial production involves thorough understanding of cell-polymer 
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interactions in order to prevent or minimize undesirable cellular responses.
6
 Applications 
such as polymer-coated stents for drug, protein and hormone delivery, tissue engineering 
(TE) and other polymer/cell combinations such as artificial corneas, cartilage and bone, 
makes it very important to understand biological response.
5
 Biomaterials have made great 
impacts on medicine and current technology and will therefore impact biomedical 
application advancements. As the aging population of developed countries continues to 
grow, the demand for biomedical products to enhance life quality and longevity will 
proportionally increase. 
The focus of this thesis will be on preparing new potential biomaterials based on butyl 
rubber (IIR)-polyester copolymers. The incorporation of an elastomeric component in the 
biomaterial is especially important when considering its ability to mimic soft tissues. 
Because humans predominantly consist of soft tissues, biomaterials that possess similar 
mechanical and viscoelastic properties have potential for application in a multitude of 
areas ranging from vascular prostheses (blood-interfacing implants) to breast implants 
(non-blood-interfacing). Although elastomers are attractive due to their compliance with 
soft or cardiovascular tissues, mechanical property enhancements may be required for 
various applications. Therefore, in order to provide strength and rigidity, the 
incorporation of polyesters (hard phase) with IIR (soft phase) will provide physical 
crosslinks. The properties presented by these copolymers may be analogous to 
thermoplastic elastomers (TPE). TPEs are typically composed of a phase which is hard at 
ambient temperature, while the other is elastomeric. Phases are most commonly bonded 
chemically through block/graft copolymerization.
7
 Without the hard phase, the elastomer 
phase would flow freely, rendering it unsuitable for biomedical applications requiring 
rigidity. For example, elastin and collagen are important components of various arteries. 
Although functions of such soft tissues vary, it is the combination of the elastomeric 
elastin with harder collagen that provides appropriate mechanical properties. With this 
understanding, it will be interesting to investigate how the properties of IIR can be varied 
chemically, physically and biologically to afford potential biomaterials.  
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Chapter 2 
2 Background and Literature Review 
2.1 Polymers as Biomaterials 
Polymers are particularly interesting for use as biomaterials; their chemical, physical and 
biological properties vary across a wide variety of structures, rendering them useful in 
many different applications. In addition, through modification of the polymer backbone, 
these properties can be specifically tuned. However, it is important to understand how 
each polymer or polymeric system will impact its performance. Since applications can 
range from soft tissue/organ replacement, drug delivery, wound dressings, to even 
reconstruction of bone deficiencies, investigating a range of varying polymers to facilitate 
new materials for biomedical applications has become increasingly apparent. 
2.2 Natural Polymers 
Biomedical applications involving the use of natural polymers such as collagen, chitosan 
and alginate date back thousands of years. Natural polymers possess the obvious 
advantages associated with biocompatibility; they do not elicit inflammatory responses or 
other unsuitable side-effects that may result through the use of synthetic systems. 
Although synthetic polymers are desirable as their properties can be tuned and controlled 
with ease, the inherent issues stemming from biocompatibility still present natural 
polymers as viable candidates for use as biomaterials.
8
 There are a wide variety of natural 
polymers, leading to different avenues and applications. Proteins, such as collagen and 
silk fibroin; polysaccharides, such as chitosan, hylauronic acid, alginates, dextrans and 
starch-based materials; and microbial polyesters, such as polyhydroxyalkanoates are all 
viable natural materials that are under current investigation for biomedical usage. 
However, focus will be directed toward some notable materials including collagen, 
chitosan and hyaluronic acid. 
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2.2.1 Collagen 
Collagen is the most abundant protein in the body, which is owed to its high composition 
in both skin and other musculoskeletal tissues.
9
 Type-I collagen (skin, tendon and bone) 
is the most prevalent in mammals, providing the structural integrity and architecture.
8
  
Type-I is composed of three polypeptide subunits consisting of similar amino acid 
compositions: 33% glycine (Gly), 25% proline (Pro) and 25% hydroxyproline (Hyp). 
These subunit chains allow collagen to undergo transcription, translation and post-
translational modification processes in fibroblasts and osteoblasts. Since these amino acid 
subunits form polypeptides in typical sequences, it causes collagen to have a helical 
structure, thereby providing it with its mechanical strength and resiliency (Figure 2.1).
10
 
Moreover, its flexibility can be tuned by increasing the glycine content if it is required for 
a specific application. It is because of this mechanical strength that utilizing collagen for 
biomedical applications such as scaffolds,
11,12
 drug-delivery systems,
13,14
 shields for 
contact lenses,
15
 sponges,
16
 hydrogels,
17,18
 nanoparticles
19,20
 and skin replacements,
21,22
 is 
advantageous. In addition, its low antigenicity and good cell-binding properties make it 
attractive for TE applications.
23,24
 Collagen sponges have been fabricated for cell and 
tissue attachment,
25,26
 and to also enhance bone formation due to osteoblast 
differentiation.
27,28
 However, because it requires crosslinking agents for certain 
applications, this may render it unsuitable due to toxic byproducts. 
 
Figure 2.1 – Common tripeptide sequence of collagen composed of glycine (Gly), 
proline (Pro) and hydroxyproline (Hyp) leading to helical structure. (Reprinted 
from Progress in Polymer Science, 35/4, Puppi et. al., Polymeric materials for bone 
and cartilage repair (403-440). Copyright (2010), with permission from Elsevier. 
5 
 
2.2.2 Chitosan 
Chitosan is a linear polyelectrolyte copolymer, which is composed of randomly 
distributed 2-acetamido-2-deoxy-β-D-glucopyranose and N-acetyl-D-glucosamine 
(chitin) units. Most units in the copolymer consist of the deacetylated version (2-amino-
2-deoxy-β-D-glucopyranose) making it hydrophilic thereby promoting cell adhesion, 
proliferation and differentiation (Figure 2.2). Chitosan, like most natural polymers, is 
biocompatible, and possesses other desirable properties including high charge density, 
non-toxicity and mucoadhesion, rendering it appropriate for pharmaceutical and cosmetic 
applications.
8
 The chain of chitosan is somewhat stiff, stabilizing a liquid crystalline 
phase in acetic acid.
29
 The predominantly explored applications of chitosan involve non-
viral gene delivery due to its cationic nature allowing complex formation with DNA 
molecules.
30-32
 Moreover, chitosan-based products are also appropriate for the delivery of 
chemotherapeutics such as antibiotics, antiparasitics, anaesthetics and painkillers, via 
routes involving injectable chitosan hydrogels. Chitosan’s novel properties make it an 
appropriate natural polymer for property modification to result in a viable biomaterial for 
cell therapy, TE and gene therapy. These TE applications include skin, bone, cartilage, 
liver, nerve and blood vessel.
33,34
 However, its chemical modification cannot correct 
deficiencies concerning mechanical weakness and instability, incapacity to maintain a 
predefined shape, as well as impurities affecting material properties.
35
 
 
Figure 2.2 – Structure of chitosan. 
2.2.3 Hyaluronic Acid 
Hyaluronic acid (HA) is an example of a polysaccharide, which consists of a high 
molecular weight (MW) and linear backbone. Typically referred to as hyaluronan, this 
polymer exists as a polyanion with alternating disaccharide units of β-1,3-N-acetyl-D-
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glucosamine and glucuronic acid (Figure 2.3). HA is the main component of the 
extracellular matrix (ECM). Not only does it serve as structural support, but it also 
interacts with proteins, proteoglycans and other bioactive molecules, thereby contributing 
to regulating processes such as cell behaviour, inflammation, angiogenesis and healing.
36
 
Again, good biocompatibility as well as viscoelastic properties render HA attractive for 
delivery systems, cell encapsulation; but most notably for TE due to its availability and 
chain size manipulation. Although suitable for ECM remodeling because of cellular 
interactions, its hydrophilicity does not favour cell attachment and tissue formation. In 
order to alleviate these deficiencies, conjugation to collagen and fibronectin can be 
performed to improve cellular interactions.
37
 
 
Figure 2.3 – Chemical structure of hyaluronic acid. 
2.2.4 Applications 
Natural polymers are somewhat limited by the properties that they possess. In order to 
modify their properties, they must be changed in a way that does not incorporate 
synthetic materials. The advantage of natural polymers is their ability to interact within 
biological systems in a reproducible and predictive manner; changing their properties 
through a synthetic means may render these advantages obsolete. Chitosan has been 
found interesting for a variety of applications, primarily owed to its degradation and 
solubility, which can be tuned by substituting isobutyl at deacetylated sites without 
altering its bioactivity.
38
 Chitosan does not exhibit foreign body reactions, thus 
minimizing inflammatory responses, making it attractive for a range of in vivo 
applications.
39
 For stent applications, there currently is one major contribution that 
consists of a self-expanding chitosan stent.
40
 The stent employs a highly de-acetylated 
version (slower degradation),
41
 implanted into the vas deferens of rats, displaying 
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adequate self-expansion. Finally, chitosan has the ability to form a high charge density in 
weakly acidic solutions, producing cationic polymers. As a result, it can interact with 
anionic polymers, negatively charged mucous membranes and DNA making it applicable 
for mucoadhesives, bioadhesive drug delivery systems and for non-viral gene delivery 
vehicles, respectively.
42-44
  
Although collagen does not interact with anionic materials, its properties, 
including enzymatic degradability and unique physico-chemical, mechanical and 
biological properties, make it an interesting material for a variety of biomedical 
applications.
9
 Collagen is the main component of the extracellular matrix, presenting it as 
a strong candidate for TE/engineering applications. Because it is natural and abundant 
amongst biological systems, it acts as a substrate for cell attachment, proliferation and 
differentiation. Many applications involving spongy collagen matrices (Promogran
®
),
45
 
wound dressing materials (Biobrane
®
 and Alloderm
®
)
46
 and bilayer skin substitutes 
(Integra
®
 Dermal Regeneration Template)
47
 have been developed and FDA approved for 
treatment of ulcer wounds and thermal injuries. In addition, collagen has also been 
investigated for usage as delivery vehicles for small molecule drugs. Current products 
(Sulmycin
®
-Implant, Collatamp
®
-G and Septocoll
®
) focus on delivery of the antibiotic 
gentamicin, resulting in prolonged local exposure with minimal systemic infiltration.
48
 
However, the main source of collagen for biomedical applications originates from 
bovine, porcine and equine skin or Achilles tendons. The wide-spread use of these 
collagen-based biomaterials is therefore unforeseeable because of deficiencies and 
variations associated with immune responses to materials derived from different species. 
In order to make these applications realizable, human-sequenced collagen will have to be 
recombinantly developed.
49
  
Lastly, HA has presented itself as a unique biomaterial due to its structure; it is a 
polysaccharide that is found in most, if not all, vertebrate tissues. HA is versatile, which 
can be owed to its varying roles in biological processes, including cell migration and 
differentiation control during embryogenesis, extracellular matrix organization and 
metabolism and regulation for wound healing and inflammation.
50
 Because of these 
properties, HA has predominantly been studied for wound dressing, TE and drug delivery 
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applications. More specifically, HA promotes angiogenesis, thereby reducing 
inflammation
51
 and its high degree of chemical functionality allows it to undergo 
crosslinking,
52
 making it appropriate for regulating wound sites and to tailor its 
degradation rate for drug delivery. However, physical and biological limitations have 
made HA impractical as a biomaterial due to its low water solubility, rapid resorption, 
short residence time and anionic surface thereby prohibiting cellular attachment and 
tissue formation.
53
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2.3 Synthetic Polymers 
2.3.1 Biodegradable 
Biodegradable synthetic polymers have been receiving considerable interest as 
biomaterials; long-term biocompatibility issues with permanent implants has turned the 
focus towards temporary therapeutic devices for a variety of applications.
9
 TE scaffolds, 
regenerative medicine, drug eluting stents for controlled drug delivery and gene therapy 
are some examples of emerging biomedical applications where biodegradable synthetic 
polymers are being investigated.
54-56
 When considering degradable polymers for different 
biomedical applications, it is important to ensure that they are bioresorbable. The 
polymeric biomaterial is not only biocompatible, but upon degradation, the body can 
effectively process and remove monomers, oligomers and byproducts.
57
  
2.3.1.1 Poly(urethanes) 
Poly(urethanes) (PURs) are an important class of polymers that have been used in a range 
of high-performance materials including films, coatings, adhesives, fibres and elastomers. 
Although they are biostable and have been extensively investigated for long-term medical 
implants, their good biological properties, biocompatibility and synthetic versatility has 
led to the development of biodegradable PURs. There are many different compounds that 
can be applied to form PURs (by means of a simple polyaddition reaction) therefore 
material properties are highly versatile.
58
 Typical preparations of polyurethanes involve a 
polyester/polyether diol (soft segment), chain extender and a bulky diisocyanate (hard 
segment). The multiblock structure is therefore responsible for giving PURs their 
elastomeric properties.
59
  
 PURs were not considered to be thermoplastic until 1958, when 
diphenylmethane-4, 4-diisocyanate (MDI) was incorporated as the bulky diisocyanate.
60
 
However, in order to realize PURs as biodegradable polymers, common diisocyanates 
such as MDI and toluene diisocyanate (TDI) cannot be employed due to their inherent 
toxicity.
9
 Incorporation of lysine diioscyanate (LDI) or 1,4-diisocyanatobutane (BDI) can 
alleviate these issues. Reacting LDI with polyester diols offers a range of applicable 
properties (Figure 2.4 for structures).
61
 For example, peptide components in PURs allow 
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active moieties (ascorbic acid and glucose) to be introduced into the polymer thereby 
promoting cell adhesion, viability and proliferation.
62
  
 
Figure 2.4 – Structural representations of diisocyanates. 
PURs possess excellent mechanical properties, including high tensile strength and 
ultimate elongation due to their chemical structure, and because of this structure, can also 
be processed via extrusion, injection molding and calendaring.
63
 The ease of 
processability makes PURs attractive for use as injectable biodegradable polymers. This 
has led to applications involving injectable hydrogels, which have been developed to 
alleviate issues with current surgical techniques. In addition, an injectable LDI-based 
polyurethane was developed (PolyNova
®
) for orthopaedic applications because of its 
good mechanical properties and fast self-setting as well as in vivo crosslinking ability. 
Finally, porous scaffolds for TE of bone and cartilage have been proposed by usage of 
PURs containing poly(caprolactone) PCL or poly(ethylene glycol) (PEG) segments due 
to superior control over crystallinity (by controlling soft segment MW) and mechanical 
properties.
64,65
 PUR-based scaffolds have also been investigated for both in vitro and in 
vivo applications, such as analyzing cell density evolution [which was comparable to 
biocompatible poly(lactic-co-glycolic acid)]
66
 and vascularization into dorsal skinfold 
chambers of mice.
67
 Although the scaffolds did not appear to elicit any inflammatory 
responses, acidic degradation of PURs autocatalyzes the degradation process and 
byproduct production can lead to in vivo inflammatory responses. 
11 
 
2.3.1.2 Poly(ortho esters) 
The development of poly(ortho esters) (POEs) produced biodegradable polymers higher 
hydrophobicity, thereby avoiding issues with bulk degradation in drug delivery 
applications.
1,68
 By imparting hydrolytically sensitive backbones, this would limit 
degradation to very slow surface erosion in aqueous environments. There are four 
families of POEs, each with varying syntheses to improve on shortcomings of the 
preceding POEs (Figure 2.5).
69
  
 
Figure 2.5 – Chemical structures of various POEs. 
Because of versatility in their synthesis through incorporation of different diols, POEs 
possess varying degradation rates, levels of pH sensitivity, and glass transition 
temperatures.
70
  For drug release applications, the rate of release depends on the rate of 
polymer hydrolysis. For example, the development of POE IV has led to the best control 
in terms of release profile for various therapeutic molecules.
71
 With unprecedented 
control over degradation rate as well as good biocompatibility evaluation of POE IV, 
research has shifted towards using it as an injectable polymer for ocular applications, 
treatment of periodontal diseases and estrus synchronization in sheep.
72
 
 
2.3.1.3 Aliphatic Polyesters 
Polyesters are defined as thermoplastic polymers with hydrolytically labile aliphatic ester 
linkages throughout their backbone. This class of polymers is interesting due to its 
diversity and synthetic versatility. These polymers can be prepared from a large range of 
monomers through ring opening and condensation polymerization, resulting in materials 
12 
 
of very different properties. Furthermore, aliphatic polyesters are all biocompatible as 
well as bioresorbable and FDA approved for a variety of applications.
73,74
 Although many 
polymers have been studied for their potential applicability as biomaterials, polyesters, 
such as poly(lactide) (PLA) and poly(caprolactone) (PCL) have recently been under 
extensive investigation due to their exceptional biocompatibility as well as good 
mechanical properties. In addition, both of these aliphatic polyesters have been shown to 
generate bioresorbable metabolites during hydrolytic degradation, establishing their high 
potential for replacing biostable polymers in time-limited applications. For example, 
during hydrolytic degradation, PCL breaks down into different constituents that are 
eventually eliminated from the body.  It is first broken down into 6-hydroxyl caproic 
acid, followed by Acetyl coenzyme A, which finally enters the citric acid cycle and is 
excreted by the body (Scheme 2.1).
75
 PLA is also advantageous in terms of degradation 
byproducts; they are metabolized into CO2 and water, or are excreted via the kidneys.
76
 
These materials have therefore been heavily investigated for controlled drug release 
systems and as orthopaedic implants.
77-79
  
 
Scheme 2.1 – Hydrolysis of PCL to 6-hydroxylcaproic acid and acetyl coenzyme A 
intermediates followed by elimination from the body through the citric acid cycle. 
Both PCL and PLA are hydrophobic polymers that can be prepared via ring-opening 
polymerization (ROP) using a variety of anionic, cationic and coordination catalysts, or 
even via free-radical ROP.
80
 The mechanisms of initiation, coordination/insertion of 
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monomer, deactivation and chain transfer for PCL with stannous octoate can be 
visualized in Scheme 2.2. First, an initiator bearing a hydroxyl-functionality (alcohol) is 
added to react with stannous octoate producing a stannous alkoxide species and 
ethylhexanoic acid (1). Next, further reaction with a second alcohol equivalent produces 
the stannous dialkoxide initiator (2); adventitious water will serve as a catalyst 
deactivator of either alkoxide initiator to a stannous alcohol derivative (3). Reaction of 
the stannous dialkoxide initiator with monomer by coordination-insertion generates the 
first actively propagating chain end, consisting of both the initiating alcohol fragment and 
active propagating centre (4). Either further propagation will occur to grow the PCL 
chain, or rapid intermolecular exchange of the stannous alkoxide moiety for a proton, 
thereby establishing a rapid equilibrium between activated and deactivated chain ends 
(5).  
 
Scheme 2.2 – Mechanism of stannous octoate polymerization of PCL: 1/2 – 
formation of stannous alkoxide initiator; 3 – deactivation of catalyst; 4 – 
coordination/insertion of monomer; 5 – chain transfer of active polymerizing centre 
to alcohol. 
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PCL, as well as two of PLA's stereochemical forms (poly-D-lactide and poly-L-lactide) 
are semicrystalline materials, exhibiting glass transition temperatures (Tg) of -60°C, 55°C 
and 60-65°C, and melting temperatures (Tm) of 59-64°C, 150-170°C and 175°C, 
respectively.
81-83
 However, the third stereochemical form of PLA, poly-D,L-lactide 
(PDLLA), is amorphous and therefore does not exhibit a Tm, rather, just a Tg of 
approximately 55-60°C. In addition, poly-D-lactide (PDLA) is denoted as D due to its 
ability to rotate a plane of polarized light to the right (clockwise, dextrorotatory); 
conversely poly-L-lactide (PLLA) is denoted L as it rotates light to the left 
(counterclockwise, levorotatory) (structures in Figure 2.6).
9
 Variations in transition 
temperatures will impact their chemical and physical properties, providing insight toward 
relative applicability in different biomedical applications.  
 
Figure 2.6 – Chemical structures of PDLA (S-enantiomer), PLLA (R-enantiomer), 
PDLLA (racemic mixture) and PCL. 
Due to physical and chemical properties, these aliphatic polyesters have significantly 
different degradation rates. PCL has been shown to break down exceedingly slowly, with 
complete degradation requiring approximately a 3-4 year period.
84
 Polymeric devices 
consisting of PCL first garnered interest for sustained drug release involving devices that 
were to remain active for over 1 year, and as slowly degrading suture materials 
(Maxon
TM
).
82
 However, polyglycolides as well as polylactides became more popular for 
drug delivery vehicles as they display the ability to completely release an encapsulated 
drug over a few weeks and be fully resorbed in 2-4 months. Although PDLLA has been 
shown to exhibit increased degradation rates, it typically starts to show mass loss and 
fully erode within 12-16 months, whereas PLLA can take 2-5.6 years to degrade in 
15 
 
vivo.
82,85
 Degradation of semicrystalline polymers such as PCL occurs in two stages when 
subjected to aqueous media. First, water diffuses into the amorphous regions, which are 
less organized and allow water to penetrate more easily. Next, hydrolytic degradation 
occurs from the edge to the centre of the crystalline domains, followed by intracellular 
degradation if the MW is less than 3000 g/mol. This explains why PDLLA degrades 
much faster as it lacks crystallinity.
86-88
 The second stage of degradation confirms that 
PCL is resorbable, as polymer fragments are uptaken into phagosomes, whereby an 
intracellular mechanism completes the degradation process. In terms of in vivo 
degradation, PCL and PDLLA behave similarly.
89
  
  PCL’s excellent biocompatibility also makes it attractive for 3D porous scaffolds 
in TE applications to direct the growth of cells and new bone at the site of 
implantation.
76,90
 Moreover, its good rheological and viscoelastic properties render it easy 
to manufacture and manipulate while providing overall structure and support.
91,92
 PCL’s 
slow degradation and mechanical support are therefore excellent attributes for this 
application. The slow degradation coupled with bioresorbability ensures ample time for 
neo-bone/tissues to form at the site of implantation without complete fragmentation of the 
biomaterial. Along with scaffolds, PCL has also been employed in various TE 
applications including bone,
93
 cartilage,
94,95
 tendon and ligament,
96
 cardiovascular,
97
 
blood vessel,
98
 skin
99
 and nerve.
100
 PCL is a highly versatile resorbable polymer and 
although there are several FDA approved drug delivery and medical devices, an increase 
in TE applications should emerge due to PCL-composite structures and their superior 
mechanical and biocompatible properties. 
 PLA’s advantages also manifest from its biodegradable nature as well as high 
strength and biocompatibility.
101
 PLA’s crystallinity depends on the ratio of D- and L-
enantiomers used. However, combinations with as little as 12% D-lactide result in the 
amorphous PDLLA grade.
102
 PDLLA is commonly used in the food packaging sector due 
to its ease of transformation (i.e. injection moulding and thermoforming), which also 
makes it attractive for usage in resorbable plating, artificial cartilage or bone, 
chemotherapeutic and pharmaceutical applications.
103
 These applications require faster 
degradation, thereby portraying PDLLA’s advantage over its crystalline counterparts, 
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PDLA and PLLA. Because of its faster degradation and moderate strength, PDLLA is 
preferably developed as a drug delivery vehicle or a scaffolding material for tissue 
regeneration.
9
   
 By considering both PCL and PDLLA as possible bioresorbable polymers in this 
study, it will provide consistency when comparing results. Although PDLLA has been 
shown to degrade more quickly,
77,89
 degradation kinetics are based heavily upon MW, in 
that higher MW polymers will take longer to degrade due to an increase in chain 
length.
104,105
 Figure 2.7 illustrates the degradation profile for PCL homopolymers with a 
linear/porous structure; linear PCL with an initial Mn of 30 000 g/mol elicited faster 
initial and overall decrease in Mn (decreasing to 30% of its initial Mn after one year).
106
 
Degradation is propagated due to hydrolytic degradation along the chain (or polymer 
backbone), via surface or bulk degradation pathways. Surface degradation is more 
predictable. The rate of hydrolytic cleavage, and therefore the production of oligomers 
and monomers, which diffuse into the surroundings, is faster than the rate of water 
infiltration into the polymer bulk. This does not cause a drastic change in MW, rather, an 
overall thinning of the polymer.  
 
Figure 2.7 – Molecular weight changes for a porous PCL structure (triangle) and a 
linear PCL structure (square). Reproduced with permission from Taylor & Francis, 
2007. 
The current study involves the investigation of PCL and PDLLA grafted onto the IIR 
backbone. IIR is known for its chemical and oxidative stability. Therefore PCL chains 
will likely be localized within the IIR copolymer, thereby undergoing a reduced rate 
degradation profile. Tethering of these polyesters to the IIR backbone will result in 
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compliance, yet stability and rigidity, perhaps making these copolymers suitable for a 
variety of applications requiring good mechanical properties such as vascular prosthetics 
or intervertebral disc replacement. 
2.3.2 PIB and IIR Copolymers 
2.3.2.1 Background 
Poly(isobutylene) (PIB) is a synthetic elastomer, which yields many desirable properties 
such as high elasticity, impermeability to gas and water, chemical stability and 
biocompatibility.  Because of these properties, PIB and its copolymers with small 
percentages of isoprene (IP) (0.5-4mol%), commonly known as IIR, have been used in a 
variety of commercial products such as the inner tubes of automobile tires, the bladders 
of sporting equipment such as basketballs and soccer balls, lubricating oils, motor fuels, 
sealants, and even as a primary component in chewing gum.
107
 Usage in these 
applications is also possible due to its low level of unsaturation, which provides a route 
for chemically crosslinking via sulfur-based curing. Crosslinking provides mechanical 
improvements as well as abrasion resistance, thereby enhancing its physical properties 
and bestowing suitability for different applications.
108
 PIB and IIR are attractive due to 
their aforementioned properties and versatility, and their ability to be (co)polymerized via 
cationic polymerization. 
 IIR was initially investigated by Gorianov and Butlerov (1870), as well as Otto 
(1927); they found oily homopolymers of IB were successfully produced by usage of 
boron trifluoride. By the 1930s, I.G. Farben Company of Germany fabricated high MW 
PIBs, possessing rubber-like properties. The drawback of PIB was its inability to undergo 
vulcanization or modification due to its fully saturated structure. Although uncurable, 
homopolymers of PIB were commercialized from Badischer of Germany and Exxon 
Chemical Company as PANOL

and VISTANEX

, respectively. Additional research in 
the 1930s conducted by W.J. Sparks and R.M. Thomas of Standard Oil and Development 
Company (Exxon) allowed further development of IB into the first curable IB-based 
elastomer, by incorporating small amounts of a diolefin, IP, into the molecule. However, 
IIR was officially introduced and commercialized in 1942.
109
 In addition, halogen 
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derivatives such as chloro- and bromo-butyl were introduced in the 1960s as 
commercially available products, which have greater variations in terms of vulcanization 
and can be cured with other general elastomers. Butyl polymers are considered specialty 
elastomers, eliciting the highest worldwide usage of all synthetic elastomers.  
 Versatility of PIB allows for the development of hybrid materials containing other 
polymers, thereby imparting new properties to PIB for specific biomedical applications. 
Demand for biomedical products is increasing in the western society due to the increasing 
population of the elderly. Diversifying PIB’s usage toward the health sector is crucial to 
satisfy the demand for products that enhance life quality and longevity. Although PIB is a 
versatile polymer, approximately 80% of total PIB is directed toward the automobile 
industry. The current clinical use of PIB-based copolymers in vascular stent coatings, as 
well as its preclinical investigation in a number of other areas such as bone cements and 
intervertebral disc replacements suggests that PIB is a highly biocompatible and 
promising material for a range of biomedical applications.
108
  
2.3.2.2 Synthesis of IIR 
Commercial IIR grades such as poly(methylpropene-co-2-methyl-1,3 butadiene) or 
poly(isobutylene-co-isoprene) are prepared by copolymerizing high purity IB and IP via 
cationic polymerization at -100°C in methyl chloride. A schematic diagram of a typical 
butyl plant can be found in Figure 2.8.
110
 Monomers and methyl chloride are purified via 
flashing and stripping. Zinc or calcium stearate and antioxidants are added to prevent 
agglomeration throughout the polymerization process. Post-reaction, the PIB product is 
separated from the slurry, dried and processed. In addition, the reaction follows a generic 
approach to provide living-like conditions, making use of conventional Lewis acid 
initiation systems, but with the addition of a Lewis base. By employing Lewis acid 
coinitiators (or activators) such as aluminum trichloride (AlCl3), alkylaluminum 
dichloride and boron trifluoride (BF3) in methyl chloride or dimethyl sulphoxide (Lewis 
base moderators), it modifies the interaction between the carbocation active centre and 
counter-ion.
111,112
 Moreover, without this modified interaction, the counterion would be 
too nucelophilic, causing the reactions to be terminated instantaneously.  
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Figure 2.8 – Commercialized IIR production: general IIR slurry polymerization 
(Reproduced with permission from John Wiley & Sons, 1990).
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 Polymerization of IB first involves the generation of a carbenium ion, which 
occurs due to reaction of IB monomer with a Lewis acid catalyst such as AlCl3 (Scheme 
2.3). Carbocation stability causes propagation to proceed mostly in successive head-to-
tail additions of monomer (either IB or IP) to the active centre.
113
 For IIR synthesis, IP 
units typically enter the chain in a trans-1,4 configuration, as opposed to 1,2 and 3,4 
modes of entry as evidenced by chemical analysis (Figure 2.9). The reaction is highly 
exothermic therefore polymerization can be controlled by decreasing the temperature. 
Methyl chloride is typically used as the reaction diluent with boiling liquid ethylene in 
order to remove excess heat.
114
 Lastly, controlling factors such as temperature, solvent 
polarity and the presence of counterions can also tune the rate of propagation. 
 
Figure 2.9 – Isoprene unit enters chain predominantly in trans-1,4 configuration. 
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Propagation continues until either termination or chain transfer occurs. Termination 
involves unimolecular rearrangement of the ion pair, causing the second last C-H bond to 
break and release a proton, generating a terminal alkene bond. Termination can also 
occur through alternate pathways such as formation of stable allylic carbenium ions, or 
by carbocation reaction with nucleophilic species including amines or alcohols. Control 
over termination allows for production of various MW IIR copolymers, capable of further 
modification. Lastly, chain transfer to a monomer unit is the typical mechanism 
governing polymerization termination (Scheme 2.3).
115,116
 The monomer effectively 
abstracts a proton from the second last carbon (of the chain), resulting in a monomeric 
carbocation. Both unimolecular rearrangement and chain transfer termination 
mechanisms result in carbocation formation, thus propagating the growth of a new 
polymer chain. However, chain transfer may also occur to solvent, impurities and 
polymer chains resulting in branched polymers.  
 
Scheme 2.3 – Cationic polymerization of IB governed by initiation, propagation and 
termination. 
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2.3.2.3 Physical and Chemical Properties of IIR 
The discovery of IIR was preceded by the desire to transform PIB into a rubbery 
copolymer that allowed for low functionality, resulting from its low level of unsaturation. 
As a result, low-modulus vulcanized networks that resist ozonolysis and oxidation can be 
produced.
117
 In addition, because of its oxidative, enzymatic and hydrolytic resistance, it 
is also biocompatible for long-term applications.
118
 Its biocompatibility is advantageous 
for applications involving medical devices in vivo (vascular prosthetics, stents, 
implantable devices, etc.), to replace materials such as PURs that may degrade, leading to 
inflammatory and fibrotic reactions.
119
 The long, fully saturated PIB segments also 
manifest physical properties such as low permeability to both gases and liquids, thermal 
stability, weathering, chemical and moisture resistance as well as vibration damping.
120
 
Very low permeability, making it advantageous for innerliner in tires, is attributed to the 
efficient intermolecular packing and high density of the PIB segment. In terms of air 
retention within tires, IIR demonstrated to be at least 8 times better than that of natural 
rubber (Table 2.1).
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 Table 2.1 – Air loss after automobile driving tests (Reproduced with permission 
from John Wiley & Sons).
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Initial Conditions Air Pressure Loss (psi) 
Inner Tube Original Pressure (psi) 1 Week 2 Weeks 3 Weeks 
Natural Rubber 28 4.0 8.0 16.5 
IIR 28 0.5 1.0 2.0 
Moreover, PIB’s compact and symmetrical intermolecular packing minimizes its 
intermolecular interactions, which is reflected by its viscoelastic properties.
121
 Having 
two methyl side groups on every other chain carbon causes a delay in elastic response to 
deformation. This can also be described as high hysteresis. Perfectly elastic materials do 
not lose energy when a load is applied to them. However, viscoelastic materials do lose 
some energy, dissipated as heat, resulting in slight permanent deformations after a given 
stress is applied. This is also related to creep in that viscoelastic materials permanently 
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deform over prolonged periods of time due to the application of small stresses (strain rate 
dependent on time). These characteristics, along with IIR’s high mechanical damping 
make it viable for various automotive applications including suspension bumpers and fan 
belts.
121
  
 In terms of chemical properties, IIR has a glass transition temperature of 
approximately -70°C and is readily soluble in nonpolar solvents.
122
 Although typical IIR 
exhibits IP contents ranging from approximately 0.5-4 mol%, it can be further increased 
to 7 mol% to examine the impact of increased functionality and unsaturation. IP acts as a 
strong chain transfer agent in the copolymerization of IB and IP, therefore conditions 
must be tuned in order to afford IIR with high mol% of IP. Moreover, the reactivity ratios 
of IB and IP monomers are similar, thus generating a randomly distributed copolymer. 
Rapid and somewhat uncontrollable polymerization rates, chain transfer and termination 
mechanisms contribute to IIR’s high polydispersity indices (PDI), ranging from 2-4.123 
High PDIs indicate that IIR and copolymers have wide molecular mass distributions.  
2.3.2.4 Modifications of IIR 
Although IIR has attractive properties and application potential, chemically crosslinking 
(vulcanizing) the elastomer improves abrasion resistance and mechanical properties. 
Commonly employed vulcanization methods include accelerated sulfur vulcanization, 
dioxime crosslinking or polymethylol-phenol resin curing. An example of sulfur-based 
crosslinking is depicted in Scheme 2.4a. Sulfur compound varieties consisting of 
thiurams, dithiocarbamates and thiazoles and concomitant temperatures of 160°C 
generate crosslinked products from highly unsaturated IIRs. Scheme 2.4b describes 
dioxime curing, where an oxidizing agent [O] oxidizes p-quinone dioxime, forming an 
active crosslinking agent, which can rapidly vulcanize at room temperature (RT). Lastly, 
Scheme 2.4c shows the general structure of a resin used for olefinic crosslinking. The 
method is dependent on the R group reactivity.  
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Scheme 2.4 – Vulcanization of IIR: a) sulfur-based crosslinking; b) dioxime curing; 
c) general structure of resin capable of vulcanization. 
 The discovery of IIR halogenations by Goodrich in the 1950s increased active 
functionalities and therefore produced versatile IIR derivatives.
124-126
 While Goodrich 
commercialized a brominated butyl (bromobutyl, BIIR) derivative in 1954, Hycar 2202, 
Exxon researchers produced chlorobutyl (CIIR) and officially commercialized their 
product by 1961. Halogenations consisted of “dark” reactions, performed with a solution 
of IIR and elemental halogens (X) in hexane at approximately 40-65°C (Scheme 2.5). 
The goal was to create a halogenated IIR compound with only 1 halogen atom per 
isoprene unit (1:1 mole ratio of X to isoprene).
127
 BIIR and CIIR possessed the attractive 
properties of IIR, as well as additional characteristics including enhanced cure properties 
(broader vulcanization techniques) and covulcanization with other high-unsaturation 
general-purpose elastomers.
128,129
 With these improvements, halobutyl tubeless tire 
innerliners could be afforded. Typical addition reactions with halogen atoms result in 
Zaitsev configuration; however, the reaction of IIR with either Cl2 or Br2 results 
predominantly in substituted allylic halide structures, in this case, the exomethylene 
isomer (Scheme 2.5). This product is the most kinetically favoured, as a result of steric 
constraints from the dimethyl-substituted carbon. However, under thermal conditions, 
this product can rearrange to the X-methyl isomer due to low strength exhibited by the 
carbon-halogen single bond. Lastly, H-X elimination can occur producing conjugated 
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dienes, rendering the copolymer useless in terms of post-halogenation curing 
techniques.
130
 
 
Scheme 2.5 – IIR bromination followed by isomerization and HX elimination. 
Chloro- and bromo- functionalities provide a greater variety in terms of curing 
methods. For instance, zinc oxide (ZnO) can be used to cure both derivatives, followed 
by simple extraction of Zn-X for post-purification.
131
 CIIR can also be vulcanized via bis-
alkylation or resin curing, producing an elastomer with increased heat resistance and 
elastic modulus (E). However, BIIR has broader vulcanization versatility due the higher 
reactivity of the C – Br bond allowing for straight sulfur cures, zinc-free cures and 
peroxide cures in decreased reaction times. In addition, it possesses a higher affinity for 
covulcanization with other unsaturated elastomers. Although chemical crosslinking of 
halobutyl does impart increased stiffness, hardness, abrasion resistance and tensile 
strength, harsh chemical-based crosslinking systems eliminate their potential for 
biomedical applications. Therefore, milder conditions involving modification of the 
backbone via installation of different chemical moieties, allows biologically acceptable 
avenues for altering chemical and physical properties of IIR. 
 IIR has been functionalized with small molecules such as acids,
132
 esters,
133,134
 
amines,
135,136
 and ethers.
137
 However, it is of interest to tune chemical and physical 
properties via copolymerization or grafting, which allow a variety of polymers to be 
directly conjugated to the IIR backbone. This should facilitate desirable chemical 
characteristics to be expressed (originating from both polymers), resulting in interesting 
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hybrid materials. Over the past 20 years, PIB has been copolymerized to afford various 
block copolymers. Poly(styrene-block-isobutylene-block-styrene), SIBS, which is a TPE, 
has been prepared by a living cationic polymerization method of PIB and styrene 
(Scheme 2.6).
118,119
 More specifically, SIBS was synthesized by first utilizing a 
bifunctional initiator, 5-tert-butyl-1,3-bis(1-methoxy-l-methylethyl)-benzene (HDCE), 
for the cationic polymerization of IB in methyl chloride/hexanes at -80ºC. After reaching 
the desired MW of PIB, styrene was added and polymerized until termination via 
methanol addition. SIBS has demonstrated desirable mechanical (ultimate tensile strength 
and hardness) and stability properties in comparison to IIR owed to the styrene (glassy 
and hard) blocks. In addition, utilizing trifunctional or arborescent initiators can afford 
three-armed star SIBS block copolymers and PIB-based hyperbranched copolymers, 
respectively.
123,138
  
 
Scheme 2.6 – Reaction schematic elucidating SIBS production via bifunctional 
HDCE initiatior. 
In order to induce a broad range of characteristics, a multitude of polymers including 
poly(methyl methacrylate) (PMMA),
139-141
 PLA
142
 and poly(ethylene oxide) (PEO),
143,144
 
have also been used to fabricate linear and star-branched block copolymers with PIB. 
Controlled polymerization conditions provide different molecular structures (di- and tri-
block, star and arborescent), thereby affording a vast library of PIB-based copolymers 
possessing various properties. 
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 IIR can also be functionalized via backbone grafting approach; directly attaching 
polymers at the IP functionality affords IIR copolymers with interesting chemical, 
physical and biological properties. In order to functionalize the unsaturated units of 
rubber, epoxidation can afford moieties that can undergo further chemical modification 
for various procedures. Zhang et. al. demonstrated epoxidation by means of 
hydroperoxide compounds, in conjunction with molybdenum compounds to catalyze the 
reaction.
145,146
 However, reaction conditions required temperatures of approximately 
90°C and durations of 10 hours.  
 
Scheme 2.7 – Synthesis of IIR-PEO graft copolymers. 
In recent work, epoxidation of the isoprene functionality was performed at RT in the 
presence of m-chloroperoxybenozic acid (mCPBA) for 1 hour, thus cleanly affording the 
epoxidized product with over 99% conversion.
147,148
 This method not only required 
milder conditions, but also eliminated the presence of transition metal catalysts and 
prevented side-product formation. The epoxidized product was transformed via acidic 
ring-opening catalysis in under 5 minutes to generate clean formation of a hydroxyl 
(OH)-moiety. Interestingly, the product opposed Zaitsev’s rule, evidenced by formation 
of the less-substituted alkene. By activation with p-nitrophenyl chloroformate (PNPC), 
PEO consisting of varying MWs could be grafted to specifically tune PEO weight 
percentage (wt%) in the IIR graft copolymers.
147,148
 Although hydroxyl-terminated PEO 
could be used for grafting, PEO with amine-termini provided full conversion of the IP 
units, due to very high coupling efficiencies (Scheme 2.7). Mild conditions coupled with 
unprecedented control over graft copolymer fabrication and PEO content suggests the 
grafting-to mechanism possesses greater industrial applicability. 
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 Kawahara et. al. also investigated graft copolymers consisting of styrene and 
deproteinized natural rubber (DPNR) in order to afford TPEs.
149,150
 In this study, graft 
copolymerization was performed by employing tert-butyl hydroperoxide/ 
tetraethylenepentamine initiating systems with DPNR to achieve grafting efficiencies 
between 70-95%. Although reasonable grafting efficiencies were afforded, control over 
MW of the poly(styrene) (PS) portion was difficult due to deactivation and chain transfer. 
In addition, the highest PS content attainable was 32wt%, which was attributed to the low 
concentration of active site availability for grafting (5 x 10
-4
 mol/mol rubber compared to 
2.2-7 mol% isoprene units for PEO-graft copolymers, Figure 2.10). The graph on the left 
of Figure 2.10 shows that a critical amount of styrene monomer is needed to maintain 
higher active grafting sites on the DPNR. Concentrations too low led to deactivation, 
while higher concentrations resulted in chain transfer. Whereas the graph on the right 
reiterates the importance of adding the correct concentration of monomer; lower feeds 
ensure that styrene is grafted to rubber particles as opposed to forming PS homopolymers 
or chain transfer products.
150
 
 
Figure 2.10 – Monomer-concentration dependence on number of active sites and 
styrene conversion (left); monomer-concentration dependence on MW of grafted PS 
and MW of PS homopolymer (Biomaterials, 29, 2008, 448-460 © 2007 Elsevier Ltd. 
with kind permission from Springer Science and Business Media). 
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2.4 Applications of IIR Materials 
IIR’s high impermeability and flex fatigue impart it with appropriate properties for use in 
tire fabrication, especially tire innerliners. The development of CIIR and BIIR butyl 
derivatives, as mentioned, led to increased curing rates and versatility as covulcanization 
with natural rubber (NR), butadiene rubber (BR) and styrene butadiene rubber (SBR) 
became possible, resulting in tires with increased durability. Desirable properties 
involving air and moisture impermeability and minimization of intercarcass pressure 
(which could cause belt edge separation and adhesion failures), have caused CIIR and 
BIIR to be used commercially.
151
 BIIR is advantageous for innerliner fabrication due to 
increased adhesion to carcass compounds, better balance properties, lower density and 
costs and flex-cracking resistance. Finally, various blends of NR and BR, NR and CIIR, 
as well as SBR and BR have been used for tire black sidewall, white sidewall and tire 
tread applications, respectively. In addition to tire applications, IIRs are also applied in 
automotive hoses including coolant, fuel line and brake line hoses because of its 
resistance to higher temperatures in under-the-hood applications.
152,153
 IIR's ability to 
dampen vibrations also makes it suitable for incorporation in dynamic parts. IIR has even 
been used in pharmaceutical applications such as IIR-stoppers and has been FDA 
approved for chewing-gum due to its biological inertness.
154
  
 PIB-based linear copolymers exhibit excellent biocompatibility, thus broadening 
their scope and applicability as potential biomaterials.
108,155,156
 For example, PIB-
copolymers are being developed as corneal shunts for the treatment of glaucoma,
157 
as 
well as in synthetic aortic valves.
158
 PIB-PMMA composites have been shown to have 
enhanced properties relative to commercial bone cements due to the incorporation of the 
elastomeric PIB into the glassy PMMA material.
139,159
 However, limitations are related to 
void formation throughout the material. These deficiencies led to inconsistencies in the 
material itself, rendering it unsuitable for clinical use in bone cements. Multiarm PIB-
cyanoacrylate (CA) copolymers have been reported as promising materials for 
intervertebral disk replacement due to the combination of CA chemistry and the 
viscoelastic properties of PIB.
160,161
 Moreover, copolymers of PIB with hydrophilic 
polymers such as poly(N,N-dimethylacrylamide) or PEO have been used to form 
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membranes that can encapsulate cells while allowing the exchange of oxygen, nutrients, 
and secreted proteins such as insulin across the membrane.
162
 PEO incorporation into IIR 
materials is also of interest due to PEO’s inherent nature to exhibit protein resistance.163 
PIB-PEO copolymers could therefore be applied in applications where biofouling has 
proven to be problematic.
117
 The level of protein adsorption resistance was investigated 
via fluorescent confocal microscopy (Figure 2.11).
148
 Figure 2.11e and f, corresponding 
to IIR-PEO graft copolymers with PEO incorporation of 24 and 34wt%, showed no 
fluorescence, indicative of protein resistance. It is important to note that with increasing 
PEO content, water solubility of IIR-PEO materials also increases. Structural integrity 
could be compromised and may be problematic for potential biomedical applications. 
 
Figure 2.11 – Fluorescence confocal microscopy images following adsorption of a 
rhodamine-fibrinogen conjugate. PEO content: a) 2%, b) 4%, c) 6%, d) 12%, e) 
24% and f) 34% (Reprinted with permission from Macromolecules 2011, 44, 6405. 
Copyright (2011) American Chemical Society). 
PIB-PS copolymers consist of soft segment elastomer and glassy PS domains, 
resulting in TPEs (Figure 2.12).
164
 These TPEs showed excellent properties, similar to 
that of IIR, whilst also exhibiting biostability and biocompatibility. With FDA approval, 
these copolymers have been used for coating drug-eluting coronary stents (DES) 
(Taxus® of Boston Scientific Co.).
164
 SIBS has also been investigated for use as a 
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corneal shunt, with results showing a decrease in inflammatory response when compared 
to polydimethylsiloxane.
165
 These advances have led to the development of the MIDI-
tube, which has demonstrated high patency in rabbit test subjects for the treatment of 
glaucoma. SIBS is also viable for the production of intraocular lenses
166
 as well as 
trileaflet heart valve replacements.
167,168
 Its excellent mechanical properties as a TPE 
makes it an attractive candidate for the aforementioned applications, however, creep 
deformation may be problematic. Optimization of the polymer chemistry and resulting 
properties is still critical for many applications. For example, when SIBS was explored as 
a potential implant material in the urinary tract, significant attachment of uropathegenic 
species such as E. coli 67 was observed, indicating that the surface properties of the 
polymer were not ideal for this application.
117
 Furthermore, there have been reported 
cases of stent coating delamination upon employment in vivo, indicating that the adhesion 
of PIB-PS copolymers to the metal materials could be strengthened.
169-171
 
 
Figure 2.12 – Cartoon representation of PIB-b-PS showing elastomeric 
entanglements (PIB) and hard segments (PS) (Reprinted from Biomaterials, 29/4, 
Pinchuk et. al., Medical applications of poly(styrene-block-isobutylene-block-
styrene) (“SIBS”) (448-460). Copyright (2008), with permission from Elsevier). 
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2.5 Evaluation of Biomaterials 
2.5.1 Chemical Characterization 
It is standard to characterize new polymeric materials by a range of techniques including 
nuclear magnetic resonance (NMR) spectroscopy, size exclusion chromatography (SEC) 
and fourier transform infrared spectroscopy (FTIR) in order to confirm their chemical 
structures. NMR spectroscopy is a technique that allows one to obtain detailed 
information on the chemical structures of molecules. While NMR spectroscopy can be 
performed to probe any nucleus with a non-zero spin, one of the most commonly 
investigated nuclei is the proton. In 
1
H NMR spectroscopy, each signal is characteristic of 
a specific proton found in a given molecular structure. The precise resonance frequency is 
affected by electron shielding, which is dependent on the chemical environment. 
Therefore, this information is important in order to determine the chemical structure and 
purity of materials. Moreover, the intensity of each peak can also allow for quantification 
of a particular component in a sample. Specifically, by integrating copolymer peaks, the 
determination of PCL or PDLLA incorporation for each copolymer can be successfully 
calculated.  
Gel permeation chromatography (GPC) is a type of size exclusion chromatography (SEC) 
that separates analytes based on hydrodynamic volume, thereby providing information 
about polymer chain length and in turn, MW. By utilizing packings comprising porous 
beads in a column, separation is achieved. Smaller analytes enter the pores, therefore 
increasing their retention time in the column, whereas larger analytes bypass the pores 
thereby eluting much faster. In conventional SEC, a number of calibration standards of 
known MW are run and their retention times are recorded in order to identify the 
relationship between retention time and MW. By relating the retention time of an 
unknown sample to the calibration curve, the unknown's MW can be determined. The 
SEC results will describe different MWs: weight average molecular weight (Mw), number 
average molecular weight (Mn), size average molecular weight (Mz) and the viscosity 
molecular weight (Mν). Polymers can then be characterized in terms of PDI: 
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1)  
Equation 1 – Definition of polydispersity index where Mn is the total weight of the 
sample divided by the number of molecules (arithmetic mean) and Mw fairly 
accounts for the contributions of different sized chains. 
Fourier transform infrared spectroscopy (FTIR) involves the absorption of infrared light, 
and is typically performed in order to identify the chemical functional groups present in a 
sample. Since every sample is different, different bonds and molecules will lead to a very 
specific spectrum, or ‘molecular fingerprint’. The analysis produces an interferogram (all 
frequencies being measured at the same time), which undergoes a Fourier transformation, 
providing a frequency spectrum. The peaks correspond to the frequencies of vibrations 
between the atoms within chemical bonds. The variations in stretching are characteristic 
of specific chemical functional groups such as carbonyls, hydroxyls, or alkenes. In 
addition, peak intensity is directly related to the amount of a specific compound or 
materials, allowing for quantitative analysis.  
2.5.2 Physical Characterization 
2.5.2.1 Water Contact Angle  
The measurement of the water contact angle (WCA) of a surface can provide insight into 
the hydrophobicity/hydrophilicty of a given surface, which can be crucial for various 
applications. A given surface at a specific temperature and pressure will exhibit a unique 
contact angle with a given liquid, which is affected by the surface energy and the 
interfacial energy between the liquid and solid (dictated by cohesion and adhesion 
forces).
172
 The critical surface energy (or critical surface tension) characterizes the 
wettability of a material. Solids that possess high critical surface energies are more 
wettable as opposed to solids with low critical surface energies, which are typically not 
wettable by most liquids. WCA is measured by drop shape analysis, where the liquid 
interface meets a solid surface as depicted in Figure 2.13.  
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Figure 2.13 – Contact angle measurement (θc) and interphase-energy between 3 
phases (values in Young’s equation found below). 
Although the results of this test will be used for qualitative analysis, the Young’s 
equation can be used to find the surface energy of a solid:
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2)  
Equation 2 – where ϴ = measured contact angle and γ is the surface tension of the 
solid-gas (SG), solid-liquid (SG) and liquid-gas (LG) interface. 
2.5.2.2 Atomic Force Microscopy 
Due to advances in probe microscopies, techniques such as atomic force microscopy 
(AFM) can provide a wealth of information on the surface topography, morphology, and 
properties of materials.
174
 AFM is advantageous over other techniques (such as scanning 
tunneling microscopy) as it can provide information concerning the nanomorphology of 
the bulk polymer. There are various AFM techniques including contact AFM, contact 
AFM in the light repulsive mode and lateral force AFM or friction force AFM. However, 
in the following study, tapping mode will be employed, which provides short-range 
forces that are still detectable, while minimizing the duration of tip-sample contact. The 
forces of tip-contact in tapping mode AFM are approximately 0.1-1 nN (in comparison to 
5-500 nN for contact mode).
175
 These low forces in combination with intermittent contact 
result in low lateral drag forces, thereby reducing damage of soft polymers.
176
 This is 
particularly important, as the IIR-copolymers are relatively soft. Low forces will help 
minimize artifacts that could be produced when the tip contacts the material surface. In 
addition, because tapping is conducted normal to the surface, it decreases capillary and 
adhesion forces, providing better resolution as compared to static scanning AFM. 
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Tapping mode is conducted through use of a cantilever and tip (probe). Forces 
occur between the cantilever and the surface, which are determined by the resulting 
deflection of the cantilever beam.  Moreover, a piezoelectric crystal causes the cantilever 
to oscillate near its resonance frequency (average of 300 kHz). The amplitude of 
oscillation decreases as the cantilever nears the surface, which is a result of energy loss 
manifested by Van der Waals and electrostatic forces. It is because of this decrease in 
amplitude that the surface features can be measured and identified.  However, an 
electronic servo must be used in order to maintain the cantilever oscillation amplitude by 
means of a feedback mechanism (adjusts the tip-sample separation distance). The 
software automatically sets the frequency to maintain the lowest possible level of force 
on the sample. In doing so, the oscillation amplitude can be accurately measured by the 
detector and input into the controller electronics of the instrument. Both the topographical 
and phase images (detections) are produced simultaneously by converting the force of the 
tip contacting the surface into an analyzable image. These images can reveal 
subnanometer surface chemical resolution due to mechanical differences amongst various 
domains.
177
 To obtain phase information, a phase shift is detected between the driving 
and actual tip response oscillation signals. When copolymers or blends are studied via 
AFM, one component displays lower surface energy and therefore typically dominates 
the top few angstroms of the surface.
178
 
2.5.2.3 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) is a commonly used imaging technique for the 
determination of surface morphology, three-dimensional (3D) structures, and can also 
provide information on chemical composition. The scanning electron microscope utilizes 
a focused beam of accelerated electrons, thus generating a variety of signals at the surface 
of the test material. Signals that produce the 3D images consist of secondary and 
backscattered electrons. Secondary electrons show morphology and topography, while 
backscattered electrons show contrasts in composition of multiphase systems. Finally, the 
electron beam scans in a raster scan pattern (image capture and reconstruction), 
combining the beam’s position with the detected signal to produce the final image. 
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2.5.2.4 Thermal Properties 
Differential scanning calorimetry (DSC) is a thermal analysis technique used to measure 
heat capacity changes of a given material with respect to temperature for detection of 
glass (Tg) and melt transitions (Tm), crystallization, mesomorphic transition temperatures 
as well as phase changes and curing/crosslinking. Understanding thermal properties 
provides insight relating to the amorphous, semicrystalline or crystalline properties of a 
given material. Amorphous materials are those that are completely non-crystalline. 
Polymer glasses and rubbers make up the majority of such materials.
113
 When amorphous 
materials are in the solid state, they are considered to be frozen polymer liquids that are 
inherently hard and brittle (at low temperatures). However, as the temperature increases 
and reaches the Tg, the polymer transforms to a rubbery material, gaining the ability to 
flow (non-frozen).
179
 The glass transition is an important temperature as it dictates 
polymer properties. Temperatures lower than Tg result in a dramatic increase in stiffness 
relative to higher temperatures, as well as changes to the physical properties (heat 
capacity and thermal expansion coefficient) of an amorphous polymer. These physical 
properties will vary at temperatures surpassing the Tg. Polymers possess different Tgs, 
which are dictated by their chemical structure, molar mass, branching, chain flexibility, 
copolymerization and molecular architecture.  
 Crystalline or semicrystalline polymers possess the ability to crystallize 
(thermodynamically favoured to reduce Gibbs free energy, G, or kinetically when cooled 
quickly) when cooled below the melting point of the crystalline phase. Many factors 
affect the rate and extent of crystallization for a particular polymer such as rate of 
cooling, orientation in the melt, specific melt temperature, tacticity, chain branching and 
molar mass.
180
 For crystalline polymers, atoms are covalently bonded into tightly packed, 
unidirectional macromolecular arrays. Unit cells are made up of repeating segments of 
polymer chains, with several segments of varying complexity in each unit. The polymer 
chains lie in one particular direction resulting in relatively weak bonding between the 
molecules, resulting in anisotropic physical properties. However, semicrystalline 
polymers are of particular importance; melt-crystallized polymers are never completely 
crystalline due to a large number of chain entanglements, thereby making it near 
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impossible to form an entirely crystalline polymer.
181
 Semicrystalline polymers contain 
both crystalline and amorphous components due to irregularities in crystal formation. 
Lamellar crystals are separated from each other by layers of amorphous phase, with 
lamellae thickness dictated by interfacial energies, Tg and Tm, under-cooling and 
segmental diffusivity.
182
 As with amorphous polymers, the transition temperatures of 
semicrystalline polymers are affected by chemical structure (stiffness, polar groups, side 
groups), molar mass and branching, as well as copolymer structure. In a copolymer, 
typically, only one of the polymers is crystallizable, causing the melt temperature to be 
impacted by incorporation into the copolymer. Main-chain stiffness is the predominant 
factor in determining Tm and Tg, resulting in a correlation that affects both of these 
properties. Typically, the value of Tg (K) is between 0.5Tm and 0.8Tg.
183
 Control over 
these transitions is particularly evident in copolymers, thereby making these materials 
useful for influencing chemical and physical properties. 
 Thermal characterization can even allow one to make inferences regarding 
mechanical properties (Figure 2.14).
184
 Rubbery materials are those that exhibit only 
glass transition temperatures due to their long polymeric chains and high degrees of 
flexibility/mobility, allowing them to undergo large deformations. In other words, the 
response of rubber is intramolecular; externally applied forces are transmitted to the long 
chains through linkages at their outer peripheries changing their conformations, thus 
causing each chain to act like an individual spring.
185
 Long chains tend to alter their 
configuration rapidly, thus allowing typical rubbers to be stretched up to 10 times their 
original length. Removal of external forces leads to rapid restoration of original 
dimensions. However, when crystalline and glassy materials are subjected to external 
forces, deformations that cause two neighbouring atoms to be altered by more than a few 
angstroms will lead to unrecoverable deformations.  
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Figure 2.14 – Temperature dependence of stiffness of typical thermoplastic 
elastomers (Reprinted from Handbook of Thermoplastic Elastomers, 1
st
 Edition, 
Drobny, Jiri George, Introduction (1-7). Copyright (2007), with permission from 
Elsevier).
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 Materials of particular interest are TPEs, which are composed of a hard 
semicrystalline phase, and a soft amorphous phase. Phases are most commonly bonded 
chemically through block/graft copolymerization.
7
 Performing DSC is therefore 
important to first determine Tgs and Tms of polymers that may be used to make up a 
particular TPE. Each individual polymer typically retains most of its characteristics, with 
slight variations. The importance of the Tg and Tm relates to the physical variations of the 
elastomer phase. As shown in Figure 2.14, temperatures below the Tg of the elastomeric 
phase cause both phases to be hard, resulting in a stiff and brittle material. However, 
above the Tg of the amorphous phase, softening occurs, producing an elastic material with 
rigidity supplied by the hard phase, causing TPEs to behave similarly to vulcanized 
rubber. With increasing temperature, the hard phase will eventually melt, producing a 
viscous fluid. Performing DSC is pertinent to understanding the ideal service temperature 
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for TPEs which will be above the Tg of the rubbery phase, but below the Tm of the hard 
phase. Overall, TPEs are attractive when compared to vulcanized rubbers due to simpler 
and milder processing methods.
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In this thesis, investigating IIR-polyester graft copolymers will provide materials 
that can be potentially processed as TPEs. Moreover, these graft copolymers may belong 
to an important family of TPEs, polyester elastomers (PEE). These TPEs share 
similarities to polyurethane and poly(amide) TPEs.
186
 Polyester elastomers, like other 
TPEs, resist deformation due to the presence of microcrystallites formed by partial 
crystallization of hard segments, which therefore function as physical crosslinks. 
Processing temperatures allow these crystallites to melt, yielding a polymer melt; such 
polymers can be shaped by moulding and retain their shape upon cooling as the hard 
segments recrystallize.
184
 This aspect could be advantageous for various applications 
involving injectable thermosets or the fabrication of specifically shaped implants. PEEs 
are also highly versatile. Varying the ratio of hard to soft segment can result in materials 
ranging from soft elastomers to relatively hard elastoplastics.  
2.5.2.5 Mechanical Properties 
Tensile testing is considered to be the most fundamental type of mechanical testing that 
can be performed on a specific material. This testing mechanism provides useful 
information on the material's ultimate tensile strength (UTS), Young’s Modulus (modulus 
of elasticity, E), yield strength and elongation at break (εb). Identifying this information is 
particularly useful for research and development, engineering design and quality control 
and specification. The instrument itself utilizes a pair of self-aligning grips where the 
sample is placed and secured, ensuring that the sample is aligned with the direction of 
pull and to avoid possible slippage (Figure 2.15). Samples are typically stretched 
uniaxally until failure by gradually increasing the tensile load (breakage). Tensile testing 
machines therefore elongate the specimen at a constant rate, continuously and 
simultaneously measuring the instantaneous applied load and resulting elongations. The 
load-deformation characteristics are dependent on the specimen size. 
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Figure 2.15 – Instron (3300 series) tensile testing instrument. 
Load and elongation are normalized to parameters of engineering stress (σ) and 
strain (ε). Stress occurs when a force (F) is applied normal to the face of an element 
(Figure 2.16a). The force transmits through the element and is balanced by an equal force 
on the opposite side, establishing equilibrium. Strain is the response of materials to an 
applied stress, causing the given material to stretch from its original length, Lo, to a final 
length of L (δL = L – Lo). Upon application of a given stress and strain response, elastic 
deformation occurs, which is described by Hooke’s law, stating that stress is proportional 
to strain. Hooke’s law allows the Young’s modulus, E, to be defined for a material using 
simple uniaxial extension given by: 
 
 
  
 
 
 
3)  
Equation 3 – Young’s modulus determination for a material at a given strain and 
stress. 
However, this relationship only occurs in the linear portion of a particular stress versus 
strain trace resulting from a tensile stress. Within the elastic limit, a material will return 
to its initial shape upon removal of the applied stress. Once the limit is surpassed, 
permanent deformation will result. The modulus, E, can be considered to be a material’s 
stiffness or resistance to elastic deformation. Higher moduli are measured in stiffer 
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materials.
187
 Certain materials, particularly polymers, do not obey Hooke’s law. When a 
uniaxial stress is applied, although there is stretching and elongation in the direction of 
the stress, this elongation causes constrictions (strains) to occur in the lateral directions 
(εt), perpendicular to the applied stress. In addition to axial stress, there exists stress 
parallel to the face of an object resulting in shear strain (Figure 2.16b) as well as equal 
tensile/compressive forces to all six faces of a cubic element, resulting in hydrostatic 
pressure stress (volume strain, or dilatation, Figure 2.16c). Therefore, as with E, there are 
the shear modulus (G) and the bulk modulus (K), showing linearity between shear stress 
and shear strain and hydrostatic pressure and dilatation, respectively: 
 
 
     
4)  
Equation 4 – Linear relationship relating the shear strain, γ to the shear stress, τ. 
 
 
     
5)  
Equation 5 – Linear relationship showing proportionality between the dilatation, Δ 
and pressure, p. 
If the material behaves isotropically (strains are equal in lateral directions), a parameter 
termed the Poisson’s ratio is defined as the ratio of lateral and axial strains: 
 
 
 
    
  
 
 
6)  
Equation 6 – Definition of Poisson’s ratio where εt is the transverse strain and ε is 
the axial strain. 
When an element is stretched axially in one direction, the element contracts in the lateral 
or transverse directions, resulting in a positive value for Poisson’s ratio, typically in the 
range between 0.25 and 0.35 (for most materials).
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 Therefore the definition of Poisson’s 
ratio (Equation 6) successfully relates all three moduli (E, G and K) to one another for an 
isotropic material as: 
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7)  
Equation 7 – Relation between Young’s modulus (E), shear modulus (G) and bulk 
modulus (K). 
 
Figure 2.16 – Definitions of uniaxial stress, strain and elastic deformation. 
(Reprinted from Nanomaterials, Nanotechnologies and Design: An Introduction for 
Engineers and Architects, 1st Edition, Ashby, Michael F., Chapter 4 – Material 
Classes, Structure and properties. Copyright (2009), with permission from 
Elsevier).
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As shown in Figure 2.17, yield properties/ductility is measured using tensile tests 
by taking the material to failure. The yield strength, σy, depicts the stress at which the 
stress-strain curve (in the linear elastic regime) for axial loading deviates by a strain of 
1% (for polymers). However, the behaviour beyond yield depends on the temperature 
relative to the polymer’s characteristic Tg. Below the Tg, most polymers are brittle and 
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exhibit brittle fracture. At temperatures approaching the Tg, plasticity is possible and once 
the Tg is reached, cold drawing is achieved. This is a large plastic (permanent 
deformation) extension at constant stress during which molecules are pulled into 
alignment with the direction of straining, followed by hardening and fracture. At higher 
temperatures, thermoplastics become viscous and can therefore be moulded. Finally, 
plastic strain, εpl, is the permanent strain that results from plasticity, defined as the total 
strain, εtot, minus the recoverable, elastic part: 
 
 
         
 
 
 
8)  
Equation 8 – Definition of plastic strain. 
 
Figure 2.17 – Stress strain curve for a polymer. Definitions of uniaxial stress, strain 
and elastic deformation. (Reprinted from Nanomaterials, Nanotechnologies and 
Design: An Introduction for Engineers and Architects, 1st Edition, Ashby, Michael 
F., Chapter 4 – Material Classes, Structure and properties. Copyright (2009), with 
permission from Elsevier).
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Polymers obey Hooke’s Law at low strains, therefore allowing the calculation of the 
Young’s modulus by using appropriate software. However, with many elastomers and 
semicrystalline polymers, the linear portion is difficult to define. Because of this, moduli 
may be determined by tangent or secant methods. The tangent is the value of E at any 
point in a curve, whereas in the secant method, the curve is bisected, and E (the slope) is 
determined for the bisecting line. 
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 Elastomers typically have very low Young’s moduli, in the approximate range of 
0.5-1 MPa, whereas semicrystalline polymers exhibit higher values for E and UTS. 
Figure 2.18a shows the broad range of moduli for a variety of material classes with large 
differences in density. Polymers and elastomers possess densities lower than metals or 
ceramics, as well as moduli below 10 GPa (elastomers specifically in the range of 1-10 
MPa). Figure 2.18b depicts the yield strain of various materials. The yield strain (σy/E) is 
the strain at which a material deviates from the elastic linear regime. It is important to 
note that elastomers, due to their extremely low moduli, display yield strains in the range 
of 1 to 10, the highest of all materials. This is important as a larger yield strain 
corresponds to greater resistance to brittle fracture, which is important for various 
biomedical applications. 
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Figure 2.18 – Material property charts showing: a) Young’s modulus and its 
relation to material density; b) Young’s modulus and material strength to defined 
the yield strain (σy/E), where a material no longer behaves elastically. (Reprinted 
from Nanomaterials, Nanotechnologies and Design: An Introduction for Engineers 
and Architects, 1st Edition, Ashby, Michael F., Chapter 4 – Material Classes, 
Structure and properties. Copyright (2009), with permission from Elsevier).
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Elastomers are unique because although they are not physically stiff, they are able 
to stretch out of the linear regime without resulting in permanent deformation. In contrast 
to elastomers, semicrystalline polymers are considered to be a mix of polymer crystals, 
randomly distributed throughout an amorphous matrix. If the amorphous phase is above 
its glass transition temperature, the polymer will be less brittle, therefore exhibiting a 
modulus of approximately 50-100 GPa.
113
 An increase in crystallinity dramatically 
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affects mechanical behaviour of a given polymer. At lower degrees of crystallinity, such 
as those achieved by grafting PCL/PDLLA onto the IIR backbone, the crystalline 
domains throughout the amorphous rubber should behave as crosslinks, producing 
stiffness by increasing crosslink density. However, because PCL/PDLLA homopolymers 
have higher degrees of crystallinity than the copolymers, the resulting moduli will be a 
combination affected by both the amorphous and crystalline regions. 
2.5.3 Biological Characterization 
2.5.3.1 Cell-Material Interaction 
Performing adequate assessment in terms of biological risks is inherently important when 
fabricating potential biomaterials. In order to properly assess biological safety, first, the 
toxicology of chemical constituents used in a potential biomaterial need to be 
scrutinized.
190
 IIR, PCL and PDLLA are considered to be biocompatible materials; 
however, modes of preparation (various chemicals/solvents) of graft copolymers could 
potentially affect their biological, material and cellular responses. Since these materials 
are intended for use in a biological system, it is important to assess if they are 
biologically compatible with tissues, to minimize risk for a given patient.
191
 In order for a 
device to be considered biocompatible, it must be able perform with an appropriate host 
response in a specific application.
192
 Measuring biocompatibility is problematic due to 
the breadth of applications, which involve the interaction of different materials within 
different biological systems. However, in order to assess biocompatibility, material 
acceptance in vivo should be used to evaluate potential applications.
193
 Furthermore, the 
International Organization for Standardization (ISO) has prepared a guideline document: 
Biological Testing of Medical Devices—Part 1: Guidance on Selection of Tests’ (ISO 
10933-1) to provide insight into testing methods that should be employed. Depending on 
whether the material will be in contact with the cardiovascular system, implanted, blood-
interfacing, skin/bone-contacting, or other will impact the relevancy of specific testing 
methods.  
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Figure 2.19 – PCL and PCL-Col (collagen) materials: confocal scanning laser 
microscopies showing differences in cell proliferation on different surfaces 
(Reprinted from Biomaterials, 25/11, Cheng and Teoh, Surface modification of ultra 
thin poly (ε-caprolactone) films using acrylic acid and collagen (1991-2001). 
Copyright (2003), with permission from Elsevier). 
 It is fundamental to explore cytotoxicities of materials, as well as interactions of 
biosystems with materials at molecular levels. Investigating the interaction between 
mammalian cells and biomaterials via spreadability, adhesion and proliferation properties 
is particularly crucial.
194
 Cells tend to communicate with their surroundings by means of 
cell-surface interactions involving the formation of focal adhesions as well as the 
clustering of integrin receptors.
195
 Physical characterization techniques that analyze 
factors such as wettability, chemical composition
196
 and mechanical
197
 and 
topographical
198
 properties can affect cell adhesion and therefore proliferation. 
Investigating cell spreading on surfaces is important as anchorage-dependent cells need 
to strongly adhere in order to differentiate and transfer signals and maintain cell 
homeostasis. Through investigation of human myoblasts cultured on PCL films, adherent 
cells did not spread and were consequently washed from the film. However, through 
surface modification to incorporate collagen (Figure 2.19), cells spread in all directions 
and experienced an increase in proliferation rate, thereby establishing a relationship 
between adhesion and cell survival capabilities.
199
 Additionally, cells that maintain a 
circular shape typically do not display actin stress fibres within the cytoplasm, which are 
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critical when determining cellular health. Shin et. al. conducted studies by seeding 
Human Mesenchymal Stem Cells (hMSC) onto surfaces of Poly(L-lactide-co-E-
caprolactone) (PLCL) and compared them to surfaces of PLCL conjugated with acrylic 
acid (AAc) and gelatin (Figure 2.20).
195
 Cells on PLCL did not exhibit any spreading, but 
through surface modification, the morphology of the cells on the gelatin-AAc-PLCL 
displayed cells polygonally elongated in shape. 
 
Figure 2.20 – Morphologies of hMSCs cultured on various substrates: B) glass 
control; C) PLCL; D) AAc-PLCL and E) gelatin-AAc-PLCL. Scale bar = 200 μm 
(Reprinted with permission from Shin, Y. M.; Kim, K.-S.; Lim, Y. M.; Nho, Y. C.; 
Shin, H. Biomacromolecules 2008, 9, 1772. Copyright 2008 American Chemical 
Society). 
 C2C12, which is a murine myoblast cell line, possesses advantages including its 
ability to rapidly differentiate, excellent fusion and production of characteristic muscle 
fibre proteins.
200
 Myoblasts, which are representative of either a muscle cell or fibre, are 
interesting to examine due to their end-to-end fusion configuration in vitro, producing 
morphologies and spatial arrangements in an elongated and predictable manner.
201
 Dugan 
et. al. fabricated cellulose nanowhiskers (CNW) to understand the proliferation of C2C12 
murine myoblasts, as well as the differentiation and fusion to form myotubes (muscle 
fibres).
200
 Focal adhesions as well as the F-actin in the cytoskeleton were stained and 
imaged with confocal microscopy to determine if the morphology of CNW surfaces 
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affected cellular growth and attachment (Figure 2.21). The top line images show 
differences in morphology in that myoblasts on the glass coverslip were less spread when 
compared to CNWs (prepared at 500 and 6000 rpm); CNWs also exhibited vinculin (light 
specks), indicating adhesivity to surfaces. Morphology differences were attributed to 
surface roughness; roughness of various materials can affect cellular growth response.
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Although stress fibres appeared on all surfaces, variations in focal adhesion orientation 
became apparent after 12 hours of incubation. 
 
Figure 2.21 – (a-f) Myoblasts stained for vinculin (light speckles), F-actin (outer 
periphery) and nuclei, scale bar = 50 μm. (a) 4 h after seeding on glass coverslip 
control, (b) 4 h after seeding on C500 surface, (c) 4 h after seeding on C6000 surface, 
(d) 12 h after seeding on glass coverslip control, (e) 12 h after seeding on C500 
surface, and (f) 12 h after seeding on C6000 surface (Reprinted with permission 
from Dugan, J. M.; Gough, J. E.; Eichhorn, S. J. Biomacromolecules 2010, 11, 2498, 
Copyright 2010 American Chemical Society). 
 Finally, protein adsorption is a spontaneous occurrence with a high level of 
importance in biomaterials and biomedical science.
203
 Although biofouling is 
nondesirable, the adsorption of cell-adhesive proteins (such as vinculin and F-actin) may 
be needed to some extent depending on the intended application. This adsorption can be 
controlled in various ways such as modifying surfaces with polymer brushes (polymer 
chains attached to a surface),
204,205
 resulting in stimuli-responsive signals such as 
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temperature, pH and light. Polymer brushes may be modified by attaching polymers that 
are known to adsorb proteins with polymers that are protein-repellent to finely tune 
overall adsorption.
206,207
 Moreover, characteristic protein adsorption exhibited by 
polymers is dictated by their specific chemical structure. For example, a predominantly 
studied protein-repellent polymer is poly(ethylene oxide) (PEO). Its protein-resistant 
properties are owed to steric repulsion, causing the polymer to prevent proteins from 
reaching the substrate surface to adsorb.
208,209
  
 
Figure 2.22 – Confocal microscopy images of C2C12 cells adhered to control and 
copolymer surfaces: a) glass (control); b) IIR (control); c) 18wt% PEO ; d) 32wt% 
PEO; e) 65 wt% PEO; f) 83 wt% PEO. Nuclei (dark inner portion) and F-actin 
fibres (lighter periphery) with image area = 0.22 x 0.22 mm (Reprinted with 
permission from John Wiley & Sons, 2013). 
Factors including grafting density, length and conformation of PEO chains can also 
influence its surface resistance to proteins.
210,211
 In particular, IIR-PEO graft copolymers 
have been fabricated for applications involving increased hydrophilicity and therefore 
emulsifying ability,
212
 as well as varying PEO incorporation to confer resistance of the 
surface to proteins.
147,148,213
 Proper growth and proliferation of cells on surfaces is 
believed to be dictated by the ability of proteins to properly adsorb to surface substrates. 
Recently, Karamdoust et al. showed that by increasing PEO incorporation into IIR-PEO 
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graft copolymers, reaching a critical PEO content (34 wt%, Figure 2.22d) caused a 
dramatic decrease in protein adsorption, evidenced by a decrease in cell adhesion.
214
  
  
51 
 
2.6 Thesis Objectives 
The goal of this thesis is to synthesize IIR-polyester graft copolymers and to study their 
chemical, physical, mechanical and biological properties in order to gauge their potential 
as biomaterials. An advantage of this approach is that rather than using chemical 
crosslinking methods that are incompatible with biomedical applications, the thermal and 
mechanical properties of the polyester components may impart enhanced strength to IIR 
and other properties that are desirable for specific applications. In addition, the slow but 
eventual degradability of the polyester component may assist in the gradual 
environmental degradation of IIR materials, which are otherwise broken down only 
extremely slowly in nature.  
The interest in IIR-polyester graft copolymers as potential biomaterials stems 
from the widespread interest in IIR for various biomedical applications. For example, 
current bone cement applications involve usage of poly(methyl methacrylate), which is 
inherently brittle.
139,140
 To overcome this issue, toughening of bone cements can be 
accomplished with IIR-graft copolymer synthesis to impart impact- and fatigue-resistance 
properties. Similarly, PIB-CA materials are intended for intervertebral disc replacement, 
however, enzymatic attack on CA moieties causes the release of toxic byproducts. PURs 
are employed for usage in vascular grafts due to their elastomeric nature, but chemical 
and mechanical deficiencies led to inflammatory (and therefore occlusion) and crack 
manifestation, respectively.
118
  
Therefore, incorporation of bioresorbable and biodegradable polyesters may 
eliminate issues associated with toxicity as well as the resistance of synthetic polymers to 
degradation for time-limited applications, including sutures and bone fixation 
devices.
57,215
   Utilization of stable polymers can lead to undesirable inflammatory 
responses, as biological systems recognize them as foreign substances. However, 
degradable polymers offer advantages for therapeutic applications, specifically in 
medicine, surgery or drug delivery.
9
 For time-limited applications involving degradation, 
bioresorbability is important as it describes materials with non-toxic byproducts that can 
be eliminated from the body through metabolic pathways.
76
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 In order to synthesize the IIR-polyester graft copolymers, the aim will be the 
development of a simple synthetic method. This will make the final materials more 
attractive on an industrial as well as biomedical level. The exploration of both "grafting 
from" and "grafting to" methods will be described. Using the more successful "grafting 
to" strategy, a small library of graft copolymers is produced to provide insight concerning 
how varying weight percentages of polyester with respect to IIR affect chemical and 
physical properties. These are characterized chemically by a variety of techniques 
including NMR and IR spectroscopy, and SEC.  
 From differences in the chemical compositions of the materials, it is demonstrated 
that differences in physical properties arise. These are assessed and compared using 
techniques such as AFM, SEM, water contact measurements, and DSC. Tensile testing is 
used to elucidate changes in the mechanical properties of the materials as a function of 
their composition and degradation studies are performed to investigate their 
degradabilities. Lastly, although the literature suggests that IIR,
216
 PCL
82
 and PDLLA
88
 
are all biocompatible materials, the toxicities and cell adhering/proliferation properties of 
the new graft copolymers are studied in this thesis. Combined, this data set provides a 
basis of important information concerning the properties of these materials for further use 
in specific applications.  
53 
 
Chapter 3 
3 Results and Discussion 
3.1 Synthesis and Chemical Characterization of IIR-PCL 
Copolymers 
3.1.1 ROP of ε-caprolactone from the IIR Backbone 
IIR-polyester graft copolymers via a "grafting from" approach was initially explored. The 
goal was to perform a ROP of ε-caprolactone from the hydroxyl-moieties of the IIR 
derivative 3.3 (Scheme 3.1). First 3.3 was prepared as previously reported,
147
 via 
epoxidation of commercially available IIR (RB-402) (3.1) to provide the epoxidized IIR 
derivative 3.2, followed by ring opening under acidic conditions to obtain 3.3. A library 
of graft copolymers were to be synthesized with varying weight percentages of PCL, as 
depicted in Table 3.1. 
 
Scheme 3.1 – Epoxidation followed by hydroxylation of IIR with 2.2mol% IP and 
subsequent ROP of ε-caprolactone from IIR backbone. 
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Table 3.1 – Varying conditions to afford IIR and PCL graft copolymers by ROP of 
ε-caprolactone from –OH moiety on IIR backbone. 
Target PCL wt% of 
Copolymer  
Time  Catalyst Amount MSA or 
Sn (Oct)2 (eq/OH Butyl)  
75  6h - overnight   1-3 
50  2.5h - 
overnight 
1-2 
25  3h - overnight 1-1.5 
10  4h - overnight 1-1.2 
The initial preparation of graft copolymers via polymerization from the IIR backbone 
hydroxyl moieties appeared successful. ε-caprolactone monomer polymerized, as 
evidenced by the triplet corresponding to PCL at 4.06 ppm (-CH2 adjacent to oxygen), 
and IB peaks were visible at 1.12 and 1.40 ppm (Figure 3.1b). Moreover, 
1
H NMR 
spectroscopy also showed that the target PCL weight percentages (10-75 wt%, as per 
Table 3.1) were obtained, based on integration of the PCL triplet at 4.06 ppm with respect 
to the IB singlet at 1.40 ppm. However, it was later found that as the graft copolymers 
were initially precipitated into methanol, this solvent also caused all free PCL oligomers 
to precipitate. When the graft copolymers were precipitated in acetone, the free PCL 
remained soluble, leaving the purified graft copolymer. Acetone and similar solvents (2-
butanone) solubilize PCL with MWs of 20 000 g/mol or lower, thereby providing a 
means to elimination of free homopolymer. Upon reprecipitation of the copolymers into 
acetone, it became apparent that the graft copolymer products mainly contained free PCL 
trapped within the rubber. Thus, ε-caprolactone was preferentially undergoing 
homopolymerization, likely from adventitious water impurities, rather than from the 
hydroxyl functionalities along the IIR backbone. Therefore subsequent precipitations of 
graft copolymers resulted in a significant decrease in PCL content. This aspect was 
confirmed by taking additional NMR spectra of the copolymer material following 
acetone precipitation (Figure 3.1c). By integrating the aforementioned peaks associated 
with PCL and IB, a large decrease in PCL relative to IIR was revealed, in comparison to 
the initial spectrum (Figure 3.1b). 
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Figure 3.1 – NMR spectra showing: a) hydroxylated IIR; b) 50 wt% IIR-PCL graft 
copolymer following methanol precipitation (label k denotes terminal methylene 
PCL); c) second precipitation in acetone of the same polymer from b), confirming a 
decrease in PCL content to 16 wt% (label k denotes terminal PCL methylene). 
Aside from 
1
H NMR analysis, issues with the ROP of ε-caprolactone from hydroxyl 
moieties along the IIR-backbone were also confirmed by SEC and DSC traces. The 
aforementioned homopolymerization of ε-caprolactone coupled with precipitations into 
methanol, caused SEC traces to display significant side peaks (at increased retention 
times), representative of a lower MW homopolymer, PCL (Figure 3.2, 50 wt% PCL). In 
addition, DSC traces also depicted two melting temperatures (Appendix F). These 
different Tms signified the existence of two different species: PCL homopolymer and IIR-
PCL graft copolymers. The lower Tm (43°C) belonged to the graft copolymer, as covalent 
attachment to IIR has been shown to decrease the melting temperature of semicrystalline 
polymers.
147
 The higher Tm value of 53°C was attributed to PCL homopolymer. Free PCL 
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chains throughout the rubber matrix would provide larger crystalline domains, thereby 
showing an increased value of Tm. However, reprecipitation of graft copolymers into 
acetone markedly increased copolymer purity as free PCL chains were removed, 
producing copolymers with PCL successfully grafted to the IP functionality. This was 
confirmed by obtaining a second SEC (Figure 3.2, 50 wt% PCL post-purification) and 
DSC trace (Appendix F), elucidating a monomodal distribution and the existence of one 
Tm, respectively.  
 
Figure 3.2 – SEC trace for 50 wt% PCL shows free homopolymer. 50 wt% PCL 
(post-purification) trace reveals homopolymer removal achieved with secondary 
precipitation. Detection was based on differential refractive index. 
Issues with the synthesis of these copolymers stems from the preference of ε-
caprolactone monomer to homopolymerize, rather than copolymerize from the sterically 
hindered –OH moieties along the IIR backbone. Reaction conditions were varied (Table 
3.1) in order to promote graft polymerization. However, the intended weight percentage 
incorporation was not achievable due to inconsistencies with grafting and the non-
reproducible nature of the ROP. 
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3.1.2 Grafting of PCL onto the IIR Backbone  
3.1.2.1 PCL Functionalization 
Based on previous findings, in order to produce the target IIR-PCL graft copolymers, an 
alternative, “grafting-to,” synthetic approach was required. Recent success in grafting 
amine-terminated PEO to a IIR derivative having activated carbonates along the 
backbone, indicated the same approach should be pursued. The first step was to prepare 
an amine-terminated PCL. Using a previously reported method,
217
 an anhydride 
derivative of di-tert-butyl dicarbonate (t-BOC)-protected β-alanine (3.6) was synthesized 
(Scheme 3.2). As shown in Scheme 3.3, commercially available PCL-OH (900 g/mol, 
3.7a, and 3500 g/mol, 3.7b) was then reacted with 3.6 to provide the protected amine-
functionalized PCL derivative 3.8a/b, which was deprotected with trifluoracetic acid 
(TFA) to provide the target amine-functionalized PCL 3.9a/b. The synthesis of PCL-NH2 
was confirmed by 
1
H NMR. The peak from the original PCL-OH polymer at δ = 3.65 
ppm, representing the terminal methylene, shifted to 4.09 ppm upon reaction with 3.6 and 
finally to 4.16 ppm after deprotection, as shown in Figure 3.3 (for 3.7a). Moreover, 
methylene peaks corresponding to β-alanine appeared at 2.51 and 3.39 ppm, as well as a 
methyl peak at 1.43 ppm belonging to the t-BOC group. The peak at 1.43 ppm 
disappeared upon deprotection, and the methylene peaks of the terminal β-alanine 
moieties shifted to 2.83 and 3.33 ppm, respectively. For functionalization of 3.7b, see 
Appendix A. 
 
Scheme 3.2 – Synthesis of t-BOC-protected β-alanine anhydride. 
58 
 
 
 
Scheme 3.3 – Functionalization of PCL (3.7a/b) by first reacting with BOC-
protected β-alanine (3.6) to produce the protected derivative (3.8a/b), followed by 
deprotection with TFA (n = 8 for 900 g/mol PCL, 3.7a, initiated with ethylene glycol 
derivative and n = 31 for 3500 g/mol PCL, 3.7b initiated with ethanol). 
In addition, Tg and Tm were provided by Polymer Source
TM 
(Table 3.2). This information 
is important in order to observe how these temperatures are affected upon fabrication of 
graft copolymers. SEC traces (Figure 3.4) showed that reaction of 3.7a and 3.7b with 
BOC-protected β-alanine (3.6) and subsequent deprotection did not significantly impact 
MWs, indicating that polymer backbone integrity was maintained. This was especially 
important during TFA deprotection to ensure that ester hydrolysis did not occur. 
Table 3.2 – PCL thermal properties (provided by Polymer SourceTM). 
Homopolymer MW (g/mol) Mn Mw PDI Tg (°C) Tm (°C) 
3.7a 900 1872 2505 1.34 Not distinct 44 
3.7b 3500 7621 9275 1.22 -64 63 
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Figure 3.3 – PCL (900 g/mol) functionalization (with k referring to the terminal 
methylene): a) 3.7a; b) 3.8a; c) 3.9a. 
 
Figure 3.4 – SEC traces of PCL derivatives throughout the functionalization 
process: a) 3.7a – 3.9a (900 g/mol); b) 3.7b – 3.9b (3500 g/mol). 
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The synthesis of amine-functionalized PCL (3.9a/b) was also monitored by FT-IR in 
order to observe N-H stretching in the 3300-3500cm
-1
 region. In congruence with 
previously established work,
218
 typical stretching and vibrations associated with the PCL 
homopolymer can be observed. Peaks at 2947 and 2866 cm
-1 
are due to CH2 vibrations, 
the intense peak at 1728 cm
-1 
is due to C=O vibrations, CH2 bending vibrations at 1472, 
1420 and 1366 cm
-1
, C(O)-O vibrations at 1246 and 1171 cm
-1 
and lastly, C-O vibrations 
at 1105 and 1047 cm
-1
. However, after reacting 3.8a/b with BOC-β-alanine, N-H 
stretching was observed at 3439 and 3393 cm
-1
, as well as -NHCO- amide bond-
stretching at 1569 cm
-1
. Moreover, after deprotection with TFA, N-H stretching appeared 
as a single peak at 3445 cm
-1
. It was important to ensure that peaks signifying the 
presence of N-H stretching remained after deprotection, thereby confirming the 
successful cleavage of the BOC group, liberating the amine-functionality for subsequent 
copolymer fabrication (Appendix C for FT-IR traces). 
3.1.2.2 Grafting of PCL to IIR 
As shown in Scheme 3.4, IIR derivative 3.3 was activated with PNPC as per previous 
methods (3.13).
147
 Following the Gillies group's protocol for the grafting of amine-
functionalized PEO, the amine-terminated PCL 3.9a/b was then reacted with the 
activated IIR derivative (3.13) in the presence of DMAP at 60
o
C overnight (Scheme 3.5). 
In order to purify each graft copolymer, redissolving in dichloromethane (DCM) with 
subsequent water washing and multiple precipitations successfully removed residual 
homopolymer (PCL) as well as impurities relating to 4-nitrophenyl carbonate. By 
precipitating into acetone, it ensured that PCL polymers were removed. Yields were 
typically in the range of 75-85%, with lower yields corresponding to graft copolymers 
with higher percentages of aliphatic polyester incorporation. Increasing the fraction of 
polyester incorporation could therefore increase the copolymers’ ability to dissolve in 
acetone during purification.  
 Upon removal of ungrafted polyester homopolymers, the resulting graft 
copolymers were characterized by 
1
H NMR, FTIR, DSC and SEC. Conversion of the 
activated carbonates to carbamates upon successful grafting was revealed by shifts in 
1
H 
NMR peaks (4.8-5.3 ppm) corresponding to the exo alkene and the C-H in the α-position 
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to the activated carbonate (Figure 3.5). In order to quantify PCL weight percentage, the 
1
H NMR peak corresponding to the PCL methylene triplet at 4.06 ppm (-CH2 adjacent to 
oxygen) was integrated and compared against the PIB methylene (-CH2) peak at 1.41 
ppm.   
 
Scheme 3.4 – p-nitrophenyl chloroformate (PNPC) activated rubber synthesis. 
 
Scheme 3.5 – Synthesis of PCL graft copolymers: 3.14 – 15 wt% PCL (n=8); 3.15 – 
32 wt% PCL (n=31); 3.16 – 44 wt% PCL (n=31). 
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Figure 3.5 – 1H NMR spectra (CDCl3, 600MHz) of a) activated IIR; b) copolymer 
3.15; and c) copolymer 3.16 showing how PCL content can be determined based on 
the relative intensities of PCL to PIB, as well as reaction conversion determination 
based on peaks from 4.8-5.3 ppm. 
The appearance of a side-peak in SEC traces would indicate the presence of free 
homopolymer. However, as observed in Figure 3.6, free PCL associated peaks did not 
appear at their corresponding higher retention volumes (as compared to graft copolymers) 
validating homopolymers were successfully grafted to the IIR backbone. However, 
performing SEC analysis on IIR graft copolymers has been found to be problematic.
132,148
 
Increasing PCL content should reflect an increase in MW, but this was not observed. 
Instead, graft copolymers with increasing PCL content eluted at higher volumes; 
polymers therefore behave anomalously on the column, as previously revealed in our 
group by light scattering analysis. The SEC traces were limited as characterization tools 
to ensure complete removal of ungrafted homopolymers, due to the inability to accurately 
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determine the MW data from these measurements. PCL content was controlled by 
varying the MW of homopolymer (900 and 3500 g/mol) as well as the number of 
equivalents relative to PNPC groups (1.0 and 0.8 equivalents of 3500 g/mol PCL-NH2) to 
produce a small library of graft copolymers 3.14-3.16 (Table 3.3). 
 
Figure 3.6 – SEC traces for: ungrafted IIR (3.1) and each IIR-PCL graft copolymer 
(3.14-3.16). 
Table 3.3 – IIR-PCL graft copolymers. 
Copolymer PCL 
MW 
(g/mol) 
Equivalent 
(PCL -NH2) 
Functionalized 
Isoprene Units 
(%) 
PCL 
Content 
(wt%) 
Mw 
(kDa) 
Tg 
(°C) 
Tm 
(°C) 
3.14 900
 
1.2 100 15 504 -67 none 
3.15 3500 0.8 85 32 395 -65 44 
3.16 3500 1.2 100 44 458 -62 50 
DSC measurements were also performed in order to determine Tg and Tm for each graft 
copolymer. The Tgs of the graft copolymers were all very similar and were in the 
expected range for both IIR (-70 °C) and PCL (-64 °C). Previous studies where PEO-IIR 
graft copolymers were synthesized indicated that crystalline PEO homopolymer of 2000 
g/mol, which displayed a Tm of 58°C, was significantly reduced upon incorporation into 
the graft copolymer.
148
 Similar trends were found in the current study. Copolymer 3.16 
(44wt% PCL), combining PCL homopolymer of 3500 g/mol with an initial Tm of 63 °C 
was decreased to 50 °C upon covalent grafting to IIR. Copolymer 3.15 (32 wt% PCL), 
with fewer equivalents of PCL (3500 g/mol) in relation to isoprene units exhibited a 
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further decrease in Tm to 44°C. Copolymer 3.14 (15wt% PCL), combining PCL 
homopolymer of 900 g/mol with an intial Tm of 44°C, resulted in no apparent Tm for the 
graft copolymer. Overall, the increase in melting temperature with increased PCL content 
can be attributed to the ability of the larger PCL domains within these copolymers to 
more readily crystallize in a manner that is similar to that of the homopolymer. DSC 
traces would also show the presence of free, ungrafted PCL chains. In this case, there 
would be an additional melting peak at the temperature for the corresponding PCL 
homopolymer (Appendix H). This extra melting transition was not observed here, 
confirming the purity of copolymers.  
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3.2 Grafting of PDLLA onto the IIR Backbone 
3.2.1 PDLLA Functionalization 
IIR-PDLLA graft copolymers were synthesized in a manner similar to that of the IIR-
PCL graft copolymers. First, as shown in Scheme 3.6, a commercially available 
hydroxyl-terminated PDLLA 3.10 (2800 g/mol) was converted to the amine-terminated 
PDLLA 3.12 using the same procedure described above for PCL. The only apparent 
difference relates to the deprotection of PDLLA BOC-protected amine derivative 3.11 
due to PDLLA’s apparent sensitivity to water. Successful deprotection of PDLLA to 
afford the amine-terminated derivative (3.12) had to be performed using TFA under dry 
conditions at a temperature of 0
o
C for 2 hours. The sensitivity to water could possibly 
have caused the BOC protected β-alanine to be cleaved from the polymer terminus, and 
additionally, a reduced temperature could have had a kinetic effect on the reaction, 
thereby making it less favourable for the amine to be cleaved (when first attempted as per 
PCL deprotection conditions). In this regard, upon deprotection, a cyclic lactam was 
produced due to the cyclisation of the β-alanine amino acid. To reduce cyclisation, the 
polymer was redissolved in DCM and passed over a K2CO3 plug in order to afford 
PDLLA-NH2. Although conditions were slightly different (as compared to PCL-NH2), 
the yields obtained were good and product purity was high.  
 
Scheme 3.6 – Functionalization of 3.10 by first reacting with BOC-protected β-
alanine (3.6) to afford 3.11, followed by deprotection with TFA (3.12). 
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Figure 3.7 – Schematic depicting PDLLA functionalization: a) 3.10 (2800 g/mol), 
starting material; b) 3.11, t-BOC protected β-alanine derivative; c) 3.12, amine-
liberated derivative. In 3.10-3.12, f represents the terminal methylene. 
Successful synthesis of 3.12 was confirmed by 
1
H NMR spectroscopy. The terminal 
methine peak found at δ = 4.36 ppm shifted to the 5.23 ppm region (overlapping with the 
C-H α to the carbonyl) where it also remained after deprotection. Furthermore, methylene 
peaks corresponding to β-alanine appeared at 2.53 and 3.42 ppm, as well as a methyl 
peak at 1.43 ppm belonging to the BOC group (Figure 3.7). In addition, SEC was also 
performed to ensure that there were no significant changes to the MW of the polymer 
during this process (Figure 3.8). Finally, FTIR was performed on 3.10, 3.11 and 3.12 to 
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ensure the appearance of the peak corresponding to amine stretching in the 3500 cm
-1
 
region, indicative of successful conversion of –OH termini to –NH2 termini of the 
PDLLA polymer. Similar absorptions were observed in accordance with previously 
reported PDLLA spectra.
219,220
 Vibration of the linear ester, carbonyl bands, C=O and 
COO, appears at 1757 cm
-1
, 1267 and 1134 cm
-1
, respectively. In addition, characteristic 
CH2 vibrations can be observed at 2997 and 2949 cm
-1
. However, N-H stretching still 
appeared upon reacting with BOC-β-alanine (similar to PCL functionalization) at 3517 
and 3435 cm
-1
 (with amide –NHCO– bond-stretching at 1512 cm-1) and remained after 
deprotection as a single peak at 3508 cm
-1
, thereby confirming successful cleavage and 
liberation of amine-termini (Appendix C for spectra). 
 
Figure 3.8 – SEC traces elucidating functionalization of PDLLA 3.10-3.12. 
PDLLA starting polymer 3.10 was provided by Polymer Source
TM 
and possesses a Tg of 
28°C (Table 3.4).
 
This information is important in order to observe how the glass 
transition temperature is affected upon graft copolymer synthesis. As was expected, 
PDLLA did not possess a melting temperature because of its structure; a racemic mixture 
of D-lactide and L-lactide results in an amorphous polymer.  
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3.2.2 IIR and PDLLA Grafting 
Using a procedure similar to that used for the synthesis of the PCL-IIR graft copolymers, 
amine-terminated PDLLA 3.12 was reacted with the activated IIR derivative (3.13)  to 
prepare graft copolymer 3.17 (Scheme 3.7). The product was purified by multiple 
precipitations into acetone. This not only successfully removed 4-nitrophenyl carbonate 
impurities, but also removed residual PDLLA polymers. Yields in the range of 85-90% 
were obtained. Graft copolymer 3.17 was characterized by 
1
H NMR, FTIR, DSC and 
SEC. In congruence with copolymers 3.14, 3.15, and 3.16, conversion of the activated 
carbonates to carbamates upon successful grafting was demonstrated by the shifts in 
1
H 
NMR peaks (4.8-5.3 ppm) corresponding to the exo alkene and the C-H in the α-position 
to the activated carbonate (Figure 3.9). PDLLA wt% was determined through integration 
of 
1
H NMR corresponding to the PDLLA multiplet from 5.13-5.23 ppm (-CH α to 
carbonyl), compared against the PIB methylene singlet at 1.43 ppm (-CH2). The PDLLA 
content of copolymer 3.17 was found to be 30 wt% (Table 3.4). FT-IR spectroscopy 
showed strong peaks associated with CH2 vibrations in the 3000 cm
-1
 region, arising from 
both PIB and PDLLA, and an intense peak at 1700 cm
-1
, characteristic of the PDLLA 
C=O stretch (Appendix E). The purity of graft copolymer 3.17 was also demonstrated via 
SEC analysis; Figure 3.10 displays a monomodal distribution, thereby confirming the 
absence of free PDLLA homopolymer. 
 
Scheme 3.7 – Synthesis of PDLLA Graft copolymer: 3.17 – 30 wt% PDLLA. 
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Figure 3.9 – PDLLA content in copolymer 3.17: determined via integration 
corresponding to PDLLA multiplet from 5.13-5.23 ppm and PIB singlet at 1.41 
ppm. 
Table 3.4 – PDLLA homopolymer and IIR-PDLLA graft copolymer: PDLLA 
content and thermal properties. 
Polymer PDLLA 
MW 
(g/mol) 
Equivalent 
(PDLLA -
NH2) 
Percentage 
Functionalized 
Isoprene Units 
PDLLA 
Content 
(wt%) 
Mw 
(kDa) 
Tg,1 
(°C) 
Tg,2 
(°C) 
Tm 
(°C) 
3.10 2800    4.7 28 none none 
3.17 2800
 
1.2 100 46 462 -63  23 none 
DSC analysis was also performed on copolymer 3.17. Contrasting with PCL, PDLLA, 
because of its amorphous nature, does not exhibit a Tm (PLLA and PDLA are both 
semicrystalline and do show Tms), rather just a Tg of approximately 28°C (Table 3.4). In 
accordance with copolymer 3.14, the DSC trace of copolymer 3.17 exhibited a slight 
change in Tg to -63°C from IIR’s Tg of -70°C. In addition, a Tg corresponding to the 
PDLLA domains was observed at 23°C. This is a similar trend to what was observed with 
IIR-PCL graft copolymers, however, the Tg of amorphous PDLLA (3.10) was affected. 
Upon incorporation into the graft copolymer, the Tg of 3.10 was effectively reduced from 
28°C to 23°C. Additionally, if present as a contaminant in the graft copolymers, the DSC 
traces would also show the existence of free, ungrafted PDLLA chains. In this case, there 
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would be an additional glass transition peak at the temperature corresponding to 3.10’s Tg 
(Appendix G). This extra glass transition was not observed here, confirming graft 
copolymer purity. 
 
Figure 3.10 – SEC traces of ungrafted IIR (polymer 3.1) and IIR-PDLLA graft 
copolymer (3.17). 
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3.3 Preparation of IIR-PCL/PDLLA Blends 
In order to observe the advantages that graft copolymers exhibit, physical blends 
consisting of IIR and polyesters were also prepared. In brief, these blends were prepared 
by dissolving IIR and either PCL or PDLLA in a common solvent, and then the solvent 
was removed. To replicate the polyester content of the graft copolymers, blends with IIR 
and 15, 32 and 44 wt% PCL as well as 30 wt% PDLLA were prepared and characterized 
by 
1
H NMR and DSC. DSC traces (Appendix I) for blends consisting of PCL (5000 
g/mol) and IIR were found to exhibit the same Tgs (-66°C) and Tms (50°C) regardless of 
PCL wt% incorporation. It is also interesting to note DSC traces for PDLLA (18 000 
g/mol) blends and IIR. PDLLA homopolymer was provided by Sigma-Aldrichwith a 
glass transition temperature in the range of 38-42°C. In this case, two Tgs were observed, 
one for IIR at -67°C and the other corresponding to PDLLA at 40°C (Appendix I). 
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3.4 Physical Characterization of Graft Copolymers 
3.4.1 Atomic Force Microscopy 
The study of IIR-polyester graft copolymer films by AFM was of interest in order to gain 
insight into the phase separation and nanoscale morphologies of these polymers. In recent 
work, Zhang et. al. have demonstrated that breakout crystallization occurs when studying 
the thermal effects on block copolymers consisting of poly(butadiene)-block-PCL (PBD-
b-PCL).
221
 Breakout crystallization occurs when a crystalline portion that exhibits 
nanometer length scale domains is subsequently heated, thus transforming it into 
regularly alternating lamellae between the crystalline and amorphous layers. This 
successfully alters (or destroys) the melt mesophase, due to the crystallization of one 
block. Although the mechanism of breakout crystallization is poorly understood, it may 
occur when the crystallization driving force is enough to overcome the energy barrier due 
to the amorphous surroundings.
222,223
 Furthermore, when considering PBD-b-PCL, it has 
been shown that PCL minority blocks do in fact break out into lamellar alternating 
structures with PBD.
224
  
Therefore, because IIR-PCL copolymers are similar to PBD-b-PCL (amorphous 
and semicrystalline domains), AFM analysis could provide interesting images of 
copolymer nanoscale structure pre- and post-annealing. Although it would be of interest 
to understand the breakout kinetics (such as crystal coalescence and growth), AFM 
equipment involving real-time imaging was not available. However, differences in 
topographical and phase images could be analyzed, indicating that the development of 
crystallization did in fact impact the surrounding amorphous microdomain structures. In 
recent work, IIR-PEO graft copolymers exhibited micrometer scale patterns when spin-
cast on to silicon wafer surfaces.
147,148
  In this case, the patterning was attributed to 
kinetic factors such as the freezing of Marangoni instabilities, as well as phase separation 
(thermodynamically driven). In this sense, it would be interesting to study the pattern 
formation with IIR-PCL graft copolymers. Although PCL, like PEO, is semicrystalline, 
its inherent hydrophobicity could possibly affect the resulting surface morphology of 
copolymers.  
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Thin films of copolymers 3.14-3.17 were prepared via spin-coating a 3 wt% 
solution of copolymer in toluene onto silicon wafers. AFM showed that full surface 
coverage was achieved; topographical and phase images were obtained and analyzed. As 
shown in Figure 3.11, the surfaces were moderately rough at the nanometer scale. The 
average roughness was found using XEI software to be 1.45, 0.394, 3.09 and 0.203 nm 
for copolymers 3.14-3.17, respectively. 
 
Figure 3.11 – Topography of copolymers: a) 3.14; b) 3.15; c) 3.16; d) 3.17. 
IIR and PCL are both hydrophobic, but because they are chemically different, 
phase separation is possible under certain conditions. Consistent with the lack of Tm in 
DSC traces, no phase separation was observed for copolymer 3.14, containing 15 wt% 
PCL (Figure 3.12a). However, upon increasing to 32 wt% PCL in copolymer 3.15, some 
nanoscale patterning was observed (Figure 3.12b). By increasing the content of PCL 
further to 44 wt% in copolymer 3.16, increased heterogeneity was observed (Figure 
3.12c). From these results, it can be concluded that upon reaching a certain PCL content, 
the PCL can separate from the melt and overcome the surface energy of IIR, which tends 
to migrate to the top of the surface (lower surface energy). The repulsive energy from the 
chemically different polymers must be great enough in copolymer 3.16 for phase 
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separation to occur, thereby producing significant microstructures and surface patterning. 
In other words, free energy minimization during microphase separation therefore results 
in interesting patterning.
225
 In the case of copolymer 3.17, the image was suggestive of 
nanoscale phase separation, but well-defined patterns were not identified. 
 
Figure 3.12 – Phase contrast of copolymers: a) 3.14; b) 3.15; c) 3.16; d) 3.17. 
Upon annealing all of these surfaces, although partial organizing of PCL domains was 
observed in copolymer 3.15, copolymer 3.16 displayed what appears to be a form of 
breakout crystallization (Figure 3.13d). Regular and alternating domains of PCL and IIR 
were formed on a nanometer scale. Perhaps the crystalline blocks were able to dissociate 
out of their microdomains and into the crystal growth front. In addition, the spin-coating 
process is kinetically driven, resulting in structures that are not thermodynamically 
favoured. However, annealing allows the copolymers to form their most 
thermodynamically favoured arrangement. Because the PCL chains are grafted at various 
points in the IIR backbone (due to 0.5-4 mol%), phase separation is restricted to nano-
scale patterning. Therefore alternating lamellae of PCL form between IIR main chains. 
Further studies would have to be performed in order to determine the nucleation, 
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coalescence and growth, however, as a preliminary study, terraced crystalline structures 
did coalesce and form ordered structures upon crystallization of PCL domains. 
 
Figure 3.13 – AFM analysis of copolymer 3.16. Before annealing: a) topography; b) 
phase contrast. After annealing: c) topography; d) phase contrast. 
Next, it was of interest to study the importance of the covalent grafting of PCL to the IIR 
backbone by imaging the physical blends of IIR with PCL and PDLLA. Topographic 
images proved that blended samples formed heterogeneous morphologies, characterized 
by the formation of micrometer-scale polyester aggregates. The dark spherical portions 
that can be observed in Figure 3.14, likely represent elastomeric particles dispersed 
throughout both polyesters in prepared blends. In congruence with Gheno et. al,.
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acrylonitrile butadiene (NBR) with poly(vinyl chloride) (PVC) blends displayed spherical 
aggregates that increased in size with increasing soft segment, NBR. From Figure 3.14a, 
it is clear that the blend with the highest percentage of IIR (15 wt% PCL) displayed larger 
spherical elastomeric aggregates (on average) when compared to polymer blends with 
higher percentages of polyester. Moreover, in comparison to the graft copolymers, 
polymer blends (with comparable polyester incorporation) showed an increase in surface 
roughness to 5.78, 16.20, 4.78, 3.29nm for 15 wt% PCL, 32 wt% PCL, 44 wt% PCL and 
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30 wt% PDLLA blends, respectively. Likely, the covalent grafting of the polyester to the 
rubber confines phase separation to the nanoscale, rather than micrometer scale. 
Physically incorporated polyesters can phase separate at any length scale and are not 
restricted by polymer dimensions. Knowing the composition of each blend also provided 
information pertaining to regions within each image. It appears that the darker regions are 
associated with the spherical elastomeric portions (depressions), forming by means of a 
coalescence mechanism.
227
   
 
Figure 3.14 – Topography images of IIR-polyester blends: a) 15 wt% PCL; b) 32 
wt% PCL; c) 44 wt% PCL; d) 30 wt% PDLLA. 
Understanding the morphology in these blends was important in order to properly 
comment on the observed phase contrast images. In agreement with other rubbery-
semicrystalline blend systems, darker regions are typically associated with softer, 
elastomeric portions.
228
 It should also be noted that PDLLA does differ from PCL due to 
its amorphous nature. Because of this, PDLLA portions appear to represent darker 
spherical regions, resulting due to the agglomeration of PDLLA. When observing the 
phase contrast images in Figure 3.15a, b and d of 15 wt% PCL, 32 wt% PCL and 30 wt% 
PDLLA, respectively, there appear to be regions outside of the major patterning, which 
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are likely attributed to blend portions consisting predominantly of IIR. However, Figure 
3.15c, corresponding to 44 wt% PCL blend does not exhibit these regions. Having 
reached a critical amount of PCL may have caused the crystalline portion to link itself, 
thus forming tightly packed domains. This phenomenon has also been observed with 
IIR/poly(butylene terephthalate) and liquid crystalline polymer blends in that increasing 
the crystalline portion to 75% resulted in the formation of agglomerates and fibril 
formation.
227
 Lastly, consistent with the graft copolymers, PCL blends of 32 wt% and 44 
wt% do appear to show lamellar patterning of larger PCL domains. However, increasing 
the weight percentage of the crystalline portion and allowing it more mobility caused an 
increase of patterning and overall complexity of observed phase contrast images. 
 
Figure 3.15 – Phase contrast of polymer blends: a) 15 wt% PCL; b) 32 wt% PCL; c) 
44 wt% PCL; d) 30 wt% PDLLA. 
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3.4.2 Water Contact Angle Measurements 
WCA evaluation is important when considering biomedical applications because 
biomaterials will likely come into contact with water, blood, or other bodily fluids. 
Understanding the material’s hydrophilicity and therefore wettability could impact its use 
in certain applications. Table 3.5 illustrates the WCAs found for copolymers 3.14-3.17, 
as well as PCL (900 g/mol, 3.7a and 3500 g/mol, 3.7b) and PDLLA (2800 g/mol, 3.10) 
homopolymers. PCL-diol with a MW of 2000 g/mol has been shown to have a contact 
angle of approximately 79°.
229
 Sessile drop analysis performed on PCL homopolymers 
showed similar contact angles of 50.9° 1.77° and 70.8° 1.48°, for PCL of 900 g/mol 
and 3500 g/mol, respectively (Table 3.5). However, increasing the MW of PCL shows 
increased contact angles; PCL of 80 000 g/mol has displayed contact angles of 107°
230
 
and 114°.
218
 Lower contact angles for lower MW polymers can likely be attributed to the 
highly hydrophilic hydroxyl termini, which can have a larger impact in the context of 
lower MW polymers. With PDLLA, similar trends were observed. Higher MW PDLLA 
(125 000 g/mol) has been shown to have a static contact angle of 95.28° 0.18°.
231
 3.10 
(PDLLA, 2800 g/mol) exhibited a lower contact angle of 66.1° 1.97° (Table 3.5). 
Table 3.5 – Contact angle of PCL and PDLLA homopolymers and copolymers. 
Homopolymer/Copolymer Contact Angle (deg) 
3.7a 50.9  
3.7b 70.8  
3.10 66.1  
3.14 
92.1 0.68 
3.15 
91.5 2.30 
3.16 
94.1 1.38 
3.17 
91.0  
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Upon grafting 3500 g/mol PCL to the IIR backbone, copolymer 3.16 showed an increase 
in contact angle to approximately 94°, whereas copolymer 3.15 showed an increase to 
approximately 91° (relative to PCL homopolymer). Copolymers 3.14 and 3.17 had very 
similar contact angles of 92 and 91° respectively. IIR has an approximate contact angle of 
91°.
232,233
 Therefore the contact angles of the graft copolymers were very similar to those 
of IIR. Although PCL and PDLLA homopolymers displayed lower contact angles, upon 
functionalization and subsequent grafting, their hydroxyl termini were no longer 
liberated. This would likely decrease their hydrophilicity, causing IIR to predominantly 
influence the contact angle. 
Contact angles of approximately 90° are within the range of typical contact angles 
for various biomaterials.
234,235
 Implanted biomaterials can be problematic for thrombosis 
formation and eliciting inflammatory responses, which are related to substrate wettability. 
Although thrombus formation occurs through a biological system known as the 
coagulation cascade, which is a healthy response of damaged tissues, thrombosis and 
occlusion are particularly problematic when polymers are used to synthesize vascular 
grafts.
236
 Thrombus formation begins with protein adsorption onto the foreign substance 
and is more pronounced in terms of nonspecific protein binding onto highly hydrophobic 
surfaces. Contact angles around 90° have not been shown to cause nonspecific protein 
binding,
237
 therefore confirming their potential application for vascular prosthetics. In 
order to confirm this, different techniques such as ellipsometry, quartz crystal 
microbalance with dissipation monitoring and surface plasmon resonance can be 
employed to determine protein adsorption. 
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3.4.3 Tensile Testing 
Uncrosslinked IIR exhibits very low mechanical strength and low Young’s Modulus. It 
was hoped that these properties could be improved through the incorporation of the 
polyesters. Therefore, the mechanical properties of the new graft copolymers were 
measured by tensile testing. The results of these tests are summarized in Table 3.6 and 
the corresponding stress-strain curves can be found in Figure 3.16. PCL and PDLLA 
have tensile strengths of 3.9 0.34 MPa (elongation at break (Eb) =61  and 41 
MPa 6 MPa (Eb = 6.0-73.7% ), as well as Young’s Moduli of 83 9 MPa and 
26.7 MPa 5 MPa, respectively.79,238-241 IIR has been shown to have E values of 
approximately 0.20-0.5 MPa
242
 and a tensile strength of 0.09 MPa (Eb = 800%),
243
 and it 
was of interest to determine how this was affected by grafting PCL and PDLLA to its 
backbone. 
By covalently combining both PCL and PDLLA with IIR, it provided rubber-
toughening, while also making the homopolymers more compliant by increasing their 
resiliency. PCL and PDLLA are quite brittle, as can be observed by their relatively low 
Ebs (i.e. brittle fracture). Graft copolymer synthesis allowed for a large increase in 
elongation (Figure 3.16). As per Table 3.6, graft copolymer 3.14 experienced a 15-fold 
increase in elongation whereas copolymer 3.17 showed a 42-fold increase (compared to 
ungrafted PCL and PDLLA). Increases in elongation prove an increased compliance, 
thereby decreasing brittle fracture that is experienced by the polyester homopolymers. 
Additionally, graft copolymers experienced dramatic increases in Young’s Moduli 
relative to IIR, which can be owed to an increase in crystallinity (due to PCL and 
PDLLA). It was interesting to note that although copolymer 3.15 has a higher wt% of 
PCL incorporation than copolymer 3.14, its stress vs. strain profile appeared to mimic 
that of elastomeric IIR more closely (Figure 3.17 for a general elastomer profile). 
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Figure 3.16 – Stress-strain curve for: a) IIR; b) copolymer 3.14; c) copolymer 3.15; 
d) copolymer 3.16; e) copolymer 3.17. 
Table 3.6 – Tensile data of graft copolymers and IIR. 
Copolymer 
Polyester % 
in Copolymer 
Young’s Modulus 
E, at 50% 
Elongation, MPa 
Young’s 
Modulus E, 
MPa 
Ultimate 
Tensile 
Strength 
(UTS), MPa 
Elongation 
at Break 
(Eb), % 
IIR 0 0.66 0.19 0.56 0.12 0.247 ± 0.010 739 198 
3.14 15 1.10 0.41 0.47 0.06 1.45 ± 0.20 1216 182 
3.15 32 1.14 0.27 0.74 0.15 1.24 ± 0.13 447 65 
3.16 44 9.57 1.13 21.66 5.90 3.92 ± 1.03 165 29 
3.17 30 3.07 0.47 2.90 0.43 4.00 ± 0.86 251 52 
By grafting PCL onto the IIR backbone, elongation was increased at varying 
amounts depending on the weight percentage of PCL incorporation onto the IIR 
backbone. The acquired data follows the expected trend; increasing the percentage of 
PCL decreases its ability to elongate (relative to IIR), reaching a maximum decrease (7X) 
by graft copolymer 3.16. Furthermore, E also increases from 0.47 MPa (copolymer 3.14) 
to about 22 MPa (copolymer 3.16). Copolymer 3.16 exhibits somewhat brittle fracture (as 
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it behaves similarly to PCL homopolymer, Figure 3.17 for semicrystalline polymer), 
whereas copolymers 3.14 and 3.15 display longer elongations and increased UTS 
(compared to IIR). In addition, the tensile strength at break (Tb), or UTS, increased 
dramatically from copolymer 3.14 and 3.15 to copolymer 3.16 by inducing a small 
change in PCL content. Although it is difficult to conclude whether true TPEs have been 
produced, confirmation of this could be accomplished via cyclic loading tests.  
 
Figure 3.17 – Stress vs Strain of a variety of materials (with permission to reprint 
from MIT OpenCourseWare, http://flic.kr/p/66XeQc). 
Lastly, it is interesting to consider the study by Xu et. al. where they investigated 
the influence of increasing the soft block in a PUR TPE.
244
 TPEs with higher hard 
segment content (40-50% soft segment weight concentration, SSC) had higher moduli 
and larger initial linear portion, whereas increased soft segment TPEs (60-70% SSC) 
showed greater elastomeric behaviour and higher recoverability (Figure 3.18). 
Mechanical properties of TPEs are generally described as materials exhibiting high 
tensile strength and elongation of at least 2 times its original length.
184
 Although the 
strengths of copolymers 3.14 and 3.15 were not significantly increased, they still display 
excellent elongation properties with partial physical crosslinking. Their greater 
elongation and better recoverability is owed to their more elastomeric behaviour. 
Comparatively, copolymers 3.16 and 3.17 possess higher strengths with moderate 
elongation. However, plasticization of the amorphous phase was still apparent. This is an 
inherent characteristic of rubbery elastomers.
245
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Figure 3.18 – Thermoplastic PURs with varying soft segment contents. (Reprinted 
from Polymer, 49/19, Xu et. al., Morphology and properties of thermoplastic 
polyurethanes with dangling chains in ricinoleate-based soft segments (4248-4258). 
Copyright (2008), with permission from Elsevier).
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From the AFM imaging, increasing to 44 wt% PCL in IIR copolymers induced 
phase separation. Therefore, one can infer that the microphase-separated structure of the 
IIR-PCL films enforced the mechanical characteristics, thereby imparting increased E 
and UTS. The PCL domains that exist throughout the IIR matrix provide a physical 
crosslinking mechanism, acting as fillers to strengthen the copolymer.
243
  Copolymer 
3.17, when compared to IIR, also showed increases in Young’s Modulus and UTS from 
0.56 – 2.90 MPa and 0.247 to 4.00 MPa, respectively. Comparatively, it does show 
similar trends to PCL-based copolymers in that its overall strength is increased, however, 
copolymer 3.17 (30 wt% PDLLA) has almost the same UTS as copolymer 3.16 (44 wt% 
PCL). This is consistent with literature results in that PDLLA does display higher 
strengths than PCL. Overall, homopolymers of PCL and PDLLA are extremely brittle. 
For applications involving vascular grafts, compliance and a material’s ability to stretch 
are of paramount importance.
246
 Therefore graft copolymer synthesis effectively tunes 
and enhances the mechanical properties of IIR. 
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In biomedical applications, UTS and elongation are factors that govern suitability 
of a material for a given application. For example, elastomeric materials display physical 
properties that render them useful for implants involving soft or cardiovascular tissue.
2,247
 
The vascular wall consists of elastin, collagen and smooth muscle with Young’s Moduli 
ranging from 0.3-0.6 MPa, 100-2900 MPa and 0.006 MPa, respectively.
107
 Moreover, 
elastin and collagen exhibit tensile strengths 0.36-4.44 MPa and 5-500 MPa. Therefore 
for vascular stent applications, materials need to be extensible, allowing for vascular 
dilation and constriction. Although mechanical properties of different soft tissue can be 
mimicked by graft copolymers 3.14-3.17, it is important to note that many complex 
factors dictate an effective vessel. For example, arteries are anisotropic, pulsatile, 
compliant and thrombosis-resistant. Because of these complexities, in vivo testing of 
possible prosthetics is critical when determining practical applicability.  
Implantable materials need to reflect the mechanical behaviour (stresses/strains) 
of the tissues that they are either replacing or supporting. It is apparent from Figure 3.19 
that the diversity of toughness and E values of biological tissues requires a range of 
biomaterials to be developed. Bone and tooth enamel require high moduli and moderate 
UTS, due to their high-strength but brittle characteristics. However, collagen-rich tissue 
such as intervertebral discs has moderate compliance and toughness because strength 
needs to be maintained at higher strains. Figure 3.19 also depicts soft tissues with varying 
levels of toughness and (lower) modulus combinations. However, successful clinical 
implants typically have extremely high UTS (10-100MPa), which is much larger than 
living tissue UTS (0.01-10MPa). Therefore, materials are needed with lower toughness 
and moduli for cartilage, cardiovascular tissue and orthopaedic soft tissue. Copolymer 
3.16, with a UTS of approximately 4 MPa and a Young’s Modulus of 22 MPa could 
potentially serve as an implantable device for orthopaedic deficiencies, while copolymer 
3.17 may be appropriate for softer cardiovascular tissue. 
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Figure 3.19 – Toughness-Modulus plot for current implant materials and the 
mechanical regions for orthopedic hard tissue, orthopedic soft tissue, and 
cardiovascular tissue. (Reprinted with permission from Taylor & Francis, 2013).
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Figure 3.20 – Stress-strain curve for: a) 15 wt% PCL blend; b) 32 wt% PCL blend; 
c) 44 wt% PCL blend; d) 30 wt% PDLLA blend. 
It was also important to demonstrate the superiority of covalent graft copolymer 
mechanical properties when compared to simple, physical blends. As revealed by AFM 
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imaging, not having PCL or PDLLA covalently linked to the IIR backbone resulted in 
free domains of polyester to be dispersed throughout the blend. Because domains were 
randomly dispersed, thereby causing a lack in consistent ordering or patterning, this 
manifested mechanical deficiencies, which were attributed to brittle PCL and PDLLA. 
These deficiencies are predominantly characterized by the blends’ inability to withstand 
higher stress loads (Table 3.7). Moreover, the blends were much weaker when compared 
against their respective copolymer in terms of UTS. Figure 3.20 exhibits stress-strain 
plots for PCL (15-44 wt%) and PDLLA (30 wt%) blends, showing what appears to be an 
excess of noise, caused by the irregular composition of each blend. The blends’ yield 
strengths are so high under tension that their yield strengths can never be reached because 
the materials fracture first (linear regime followed by fracture, no plastic deformation). In 
order to properly measure their yield strengths, unique tests that suppress fracture are 
needed. One that may be employed is referred to as the compressive crushing strength; 
however, this provides the elastic limit, σel, rather than the yield stress, σy. 
Table 3.7 – Tensile data of polymer blends. 
IIR – 
Polyester 
Blend 
Polyester 
% Relative 
to IIR 
Young’s 
Modulus E, at 
50% Elongation, 
MPa 
Young’s 
Modulus E, 
MPa 
Ultimate 
Tensile 
Strength 
(UTS), MPa 
Elongation 
at Break 
(Eb), % 
15 wt% 
PCL 
15 0.79 0.15 1.76 1.57 0.28 ± 0.038  516 114 
32 wt% 
PCL 
32 0.95 0.18 2.29 2.06 0.18 ± 0.025  271 76 
44 wt% 
PCL 
44 1.20 0.14 5.30 2.33 0.18 ± 0.043  141 52 
30 wt% 
PDLLA 
30 N/A 15.11 4.51 0.62 ± 0.062  251 74 
As the tensile testing was performed on each blend, the sample seemed to fracture at the 
polyester domains; sample remained was still pulled in the axial direction due to IIR fibre 
attachment. The difference between many other studied IIR and thermoplastic polymer 
blends is typically the IIR is vulcanized prior to/during the blending process.
248
 In these 
cases, blends showed an increase in UTS and E. 
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It can be concluded that the graft copolymers were superior in terms of their 
strength (compared to IIR and blend systems), which is an important property when 
considering materials for implantable biomedical devices. Although graft copolymers and 
blends were non-crosslinked (unvulcanized), the strength and rigidity added by the 
aliphatic polyester covalent attachment may serve as an appropriate avenue for avoiding 
harsh vulcanization conditions. This has been coined as ‘green strength’: the strength, 
cohesiveness, dimensional stability, and extensibility of rubber compounds prior to 
curing/vulcanization.
228
 By avoiding vulcanization, graft copolymers may be considered 
viable candidates for in vivo applications.  
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3.5 Degradation Study of IIR-PCL/PLA Graft Copolymers 
PCL and PDLLA have both been shown to degrade particularly slowly. Under 
physiological conditions, PCL has been found to degrade over a period of 3-4 years,
84
 
and PDLLA degrades over approximately 12-16 months.
73,76
 IIR possesses high chemical 
stability, to the extent where it shows little to no degradation over several years. Because 
PCL and PDLLA were grafted onto the IIR backbone, it was expected that their 
degradation rates would be slowed. Since degradation rates were expected to proceed 
exceedingly slow, the focus of this study was therefore directed toward analyzing 
accelerated degradation rates by subjecting samples to 5M NaOH over a four month 
period.
249-251
  
3.5.1 Mass Evolution and Scanning Electron Microscopy 
Interestingly, the accelerated degradation of copolymers 3.14-3.16 resulted in 
minimal weight loss, on the order of 0.5-1% change in weight (Figure 3.21, Appendix J). 
However, such minimal change in weight could be due to experimental discrepancies 
resulting from weight measurement, associated with the detection limit and low initial 
masses. In order to correct for this, future experiments should employ samples of larger 
mass to realize greater differences pertaining to crude mass loss. However, these results 
were still quite significant when comparing to those of the control materials. Both IIR as 
well as PCL were studied under the same accelerated conditions to observe what affect 
the copolymerization of these materials had on their apparent degradation characteristics. 
The PCL control (MW approximately 5000 g/mol) fully degraded in less than 24 hours. 
In previous work, it has been found that the longer (and therefore higher MW) the 
aliphatic polyester was, slower degradation rates would therefore result.
142,252
 Although 
mass loss was not apparent, the shorter PCL grafted chains of 900 g/mol (copolymer 
3.14) in comparison to 3500 g/mol (copolymers 3.15 and 3.16) did show an increased 
rate of hydrolytic degradation, apparent in the subsequent SEC analysis section.   
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Figure 3.21 – Mass loss of copolymers 3.14-3.16, PCL and IIR controls. 
The accelerated degradation of copolymer 3.17 was also studied to gauge if 
grafting of PDLLA to IIR exhibits accelerated degradation rates when compared to IIR-
PCL copolymers. Due to time limitations, this study has only proceeded to the 2-month 
time point. Crude mass loss results were similar to copolymers 3.14-3.16 in that minimal 
weight loss, approximately 0.5-1.0 wt%, was observed (Figure 3.22, Appendix K for raw 
data). The same reasoning suggests that low perceived weight loss could be due to 
experimental discrepancies associated with the detection limit and low initial masses of 
testing materials. In congruence with PCL homopolymers, PDLLA showed complete 
degradation. However, full degradation was achieved in 5 days (compared to 24 hours), 
attributed to its higher MW (18 000 g/mol) than PCL (5000 g/mol). 
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Figure 3.22 – Mass loss of copolymer 3.17 as well as PDLLA and IIR controls. 
Next, when studying SEM results, PCL concentration appeared to significantly 
impact graft copolymer characteristics. As PCL wt% was increased, the obtained surfaces 
exhibited an increase in plasticity. It can be inferred that graft copolymers manifested 
partial TPE properties due to their excellent processability. When the discs were prepared 
via melt-pressing at elevated temperatures, the hard phase of the copolymers (PCL) 
would melt. However, upon cooling, the hard phase would solidify, producing 
copolymers with strength and elasticity. Copolymers exhibiting a greater portion of the 
hard phase therefore solidified into samples with reduced flowability, i.e. less elastomeric 
portion. Therefore copolymer 3.16 possessed higher plasticity resulting in flat and 
smooth topographies, which remained highly unchanged throughout the duration of the 
study (Figure 3.23d) and h)). Although copolymer 3.17 consists of PDLLA (not a 
semicrystalline “hard” phase), it does possess high UTS and E that are comparable to 
PCL. Perhaps these properties also caused copolymer 3.17 to have and retain smooth 
topographies over a 2 month period (Figure 3.24a and b). After just one month, IIR and 
copolymers 3.14 and 3.15 showed wrinkling, similar to their 4 month time points (Figure 
3.23). Surface irregularities, however, were particularly pronounced for copolymers 3.14 
and 3.15, resulted in corrugated surfaces. This is perhaps attributed to the degradation of 
PCL. These findings also coincide with the notion of higher MW aliphatic polyesters 
displaying a decreased degradation rate. A higher degree of PCL incorporation and MW 
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for copolymer 3.16 (compared to copolymer 3.14) suggests that there is a relationship 
between polyester concentration and the ability to maintain surface integrity.    
 
Figure 3.23 – SEM imaging taken at 100X magnification under variable pressure 
mode at To and 4 months of: a) and b) IIR; c) and d) copolymer 3.14; e) and f) 
copolymer 3.15; g) and h) copolymer 3.16. 
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Copolymers 3.14 and 3.15 and IIR displayed creep deformation resulting in 
sample wrinkling. Macroscopic images qualitatively portrayed the aforementioned 
sample deformation (Figure 3.25). As it can be seen, although there is no apparent weight 
loss, samples with higher amounts of IIR tend to shrink as they are subjected to an 
aqueous environment. Factors governing creep wrinkling can be attributed to differences 
in mechanical properties of IIR and PCL, resulting in smooth, shallow surface 
undulations due to uneven material expansion.
253
 Moreover, wrinkling has been shown to 
relax the compressive strain in the hard layer (PCL), thereby reducing elastic strain 
energy.
254
 Finally, the four month time point for copolymers 3.14 and 3.15 resulted in 
opaque materials, where the starting materials were more translucent. As PCL degraded, 
the crystallinity of the resulting degraded chains may have caused a decrease in sample 
transparency.  
 
Figure 3.24 – SEM imaging taken at 100X magnification under variable pressure 
mode at To and 2 months of: a) and b) copolymer 3.17. Macroscopic images of To-2 
months of: c) copolymer 3.17. 
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The macroscopic images are particularly interesting as there as some notable 
characteristics pertaining to copolymer 3.17 (Figure 3.24c) and 3.16 (Figure 3.25d). 
Wrinkling was almost negligible, along with maintenance of is translucent nature. These 
copolymers were not affected by creep deformation, which is favourable for different 
implantable applications such as vascular prosthetics. High amounts of degradation for 
such applications would not be favourable as they require mechanical strength and 
rigidity, along with structural integrity. Although copolymers 3.16 and 3.17 do not have 
as much strength or toughness as PIB-PMMA block copolymers, it is this decrease in 
rigidity yet structural integrity that makes them more suitable for soft-tissue-based 
applications (wound healing, sutures, intervertebral disc and articular cartilage repair).
246
  
 
Figure 3.25 – Successive macroscopic images representing To, 1 month, 2 months, 3 
months and 4 months of: a) IIR control; b) copolymer 3.14; c) copolymer 3.15; d) 
copolymer 3.16. 
There is a large interest in TE applications therefore synthesizing materials 
incorporated with biodegradable chemistries and materials that can withstand strains of 
up to 100% is highly favourable.
255,256
 It is the combination of the ability to maintain 
mechanical integrity, elongation strains and appropriate strength that makes a material 
suitable as a shape memory polymer (SMP). Although SMPs can be synthesized across a 
wide range of polymer chemistries including poly(methacrylates/acrylates), aliphatic 
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polyesters and PURs, there are several degradation and mechanical related issues.
257-259
 
Original SMPs were based upon polymers such as PLA, PCL and poly(glycolide), with 
subsequent methacrylation to allow for free-radical polymerization, procuring crosslinked 
networks for drug delivery applications.
260
 These SMPs suggested that although initial 
degradation did not affect material properties, degradation at amorphous regions 
increased crystallinity (and therefore E), thereby increasing brittle behaviour. However, 
degradation at the crystalline domains softened and decreased the modulus of the 
materials, resulting in structural deficiencies. Therefore, copolymers 3.16 and 3.17’s 
ability to maintain their structural integrity with average elongations at break of 165% 
and 251% respectively (Table 3.6), demonstrates their applicability for applications 
requiring structural maintenance and resiliency. A decrease in rigidity and maintenance 
of structural integrity is the greatest accolades a polymeric device for such specific 
biomedical applications can therefore possess. In vivo conditions would have to be 
further examined as this may compromise structural integrity (cyclic mechanical loading 
and biochemical attack). Although these resulting deficiencies are more critical for 
polymers containing hydrophilic sensitivities, hydrophobic polymers may still experience 
a loss in toughness due to internal crazing effects or gradual surface hydrolysis.
261
 
However, PCL and PDLLA reinforced with IIR provide adequate water penetration 
resistance. 
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3.5.2 Size Exclusion Chromatography 
In addition to crude mass loss measurements, SEC was also performed on polymeric 
materials at each time point. Even though there were no significant changes in mass, 
hydrolytic degradation under accelerated basic conditions may have affected copolymer 
MW profiles. Observing changes in MW will provide further insight toward 
understanding copolymer properties and applicability as biomaterials. The graphical 
representations shown in Figure 3.26 depict the change in Mn and Mw over the 16-week 
study period for copolymers 3.14-3.16 and 8 week period for copolymer 3.17. Figure 
3.26a shows that the Mn of IIR (control), copolymer 3.16 and copolymer 3.17 remained 
highly unchanged, which is attributed to IIR’s chemical stability and copolymer 3.16 and 
3.17’s increased polyester concentration. 
 
Figure 3.26 – MW data for IIR control as well as copolymer 3.14, 3.15, 3.16 and 
3.17: a) change in Mn; b) change in Mw. 
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Copolymers 3.14 and 3.15 showed gradual decreases in Mn values (Figure 3.26a). In 
congruence with this finding, Figure 3.27b shows a significant shift in the MW profile of 
copolymer 3.14. Lower MW polyester chains will degrade faster; copolymer 3.14, 
prepared with the lowest MW polymer (900 g/mol PCL), therefore exhibited the largest 
decrease in MW. Since it was prepared with lower MW PCL, cleavage of PCL chains 
underwent further degradation, resulting in oligomers that possibly diffused out of the 
polymer matrix (absence of lower MW side-peak in SEC traces). A simultaneous 
decrease in Mw was also realized, causing a dramatic but controlled decrease in MW 
profile. 
 
Figure 3.27 – MW profiles elucidating each time point over the 4 month study 
period for: a) IIR control; b) copolymer 3.14; c) copolymer 3.15; d) copolymer 3.16. 
Even though copolymer 3.15 did show a decrease in Mn, its Mw did not show a 
corresponding decrease, causing the main peak (attributed to IIR) to remain stationary 
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(Figure 3.27c) causing a significant increase in PDI. This behaviour is attributed to the 
shedding of the lower MW PCL side chains and the formation of a bimodal polymer 
distribution.  
 
Figure 3.28 – MW profile elucidating each time point over the 2 month study period 
for copolymer 3.17. 
Copolymer 3.16 did not show a significant decrease in either Mw or Mn, which is 
attributed to higher PCL concentrations. Miao et. al. showed that increasing the level of 
PCL and therefore crystalline domains in triblock copolymers of PCL and poly(sebacic 
anhydride) resulted in slower degradation profiles in both physiological and basic 
conditions.
262
 Therefore in this thesis, increasing PCL content relative to IIR may be the 
determining factor for decreased degradation. Conversely, increasing amorphous domains 
allows water to penetrate and degrade materials easier. Because of this, degradation of 
IIR-PDLLA copolymer 3.17 was hypothesized to display an increased weight loss and 
change in MW due to PDLLA’s amorphous state. However, Figure 3.28 showed that its 
MW profile remained relatively constant over the first 8 weeks of the study. 
Degradation of PCL can occur via surface or bulk processes. However, a 
combination of these pathways may have influenced IIR-PCL copolymer degradation.
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Prediction of erosion pathways is particularly complicated when grafting polyesters that 
typically abide by bulk erosion (where degradation is unpredictable and starts 
spontaneously) onto IIR (one that does not show degradation).
263
 Although mass 
remained almost constant for all samples, Mn did decrease for copolymers 3.14 and 3.15, 
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indicative of PCL chain cleavage and subsequent oligomer formation.
264,265
 Chain 
scission was homogeneous for copolymer 3.14 causing a homogenous decrease in MW 
(bulk degradation). It is interesting to note, however, that 3.16 (44 wt% PCL 
incorporation) showed little to no change in MW. This is similar to surface degradation in 
that water cannot penetrate the polymer, causing the hydrolysed byproducts to diffuse 
rapidly into the media, resulting in limited water penetration to the copolymer matrix. As 
a result, degradation will occur purely at the surface, causing the polymer to thin while 
leaving the MW intact. However, under base-accelerated conditions, autocatalysis at the 
surface would not occur. Therefore the high concentration of PCL combined with stable 
IIR caused water penetration to be negligible resulting in minimal degradation. 
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3.6 Bioassays and Compatibility 
3.6.1 Cell Growth on Polymer Films 
The evaluation of cell growth on copolymer surfaces was performed by studying the 
adhesion and topology of C2C12 murine myoblast cells on films of copolymers 3.14-
3.17, and comparing them to the same cells grown on selected control surfaces. Although 
this method is qualitative, observing cell morphology is an essential screening method for 
cytotoxicity and cell compatibility at the initial analysis stage.
191
 Observation of how the 
cells behave in terms of adhesion and viability gauges cellular response, which can be 
confirmed via the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
cytoxicity test.
191,266
 To prepare the films for these studies, copolymers 3.14-3.17 were 
prepared as 3 wt% solutions in toluene with subsequent drop-casting onto glass 
coverslips, followed by sterilization.  
Seeding myoblasts onto polymer surfaces and comparing cell proliferation to 
glass, IIR, PCL and PDLLA homopolymers, allowed for direct comparisons between 
substrate and cell morphology. After allowing an incubation period of 48 hours, cells 
were stained with DAPI (4’-6-diamidino-2-phenylindole dyhydrocholoride) and Alexa 
Fluor 568 phalloidin in order to visualize nuclei and actin protein fibers of the 
cytoskeleton, respectively. Observation of the cytoskeleton structure is crucial. 
Scrutinizing cellular spread and resulting morphologies provides qualitative comparisons 
between copolymers and control substrates to assess cellular health.
267
 In addition, cells 
were also counted on each surface for a quantitative measure. In order to do so, surfaces 
were prepared in triplicate for each sample and 3 images were taken at random locations 
to determine cell density. Utilizing cellc12 and Matlab 9 numerical values were obtained. 
By averaging these values, determining standard deviations, and performing ANOVA 
statistical measurements (Prism), confirms whether cell densities are/are not significantly 
different between each surface. Figure 3.29 shows representative images from the control 
samples (a-d) as well as from each copolymer (e-h). In this regard, one can clearly 
evaluate the results on a qualitative and quantitative basis.  
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Figure 3.29 – Growth of murine myoblast cells on: a) glass; b) IIR; c) PCL; d) 
PDLLA Cell imaging of copolymers: e) 3.14; f) 3.15; g) 3.16; h) 3.17. 
Qualitatively, the spread of the cytoskeletons for graft copolymers in Figure 3.29 
are comparable to those of the controls. A healthy cytoskeleton effectively spreads across 
the surface, ensuring proper adhesion of the cell to the test material. However, on the 
glass coverslip, as well as PDLLA and PCL controls, cells generally appeared smaller 
and less well-spread. Differences in morphology may be owed to differing degrees of 
surface roughness; smoother surfaces (such as the controls mentioned) lead to differing 
focal adhesions. It has been previously reported that uneven biomaterial surfaces (with 
higher surface roughness) can cause cells to grow differently, thereby affecting their 
surface response.
202
 In addition, recalling that the surfaces of copolymers are somewhat 
hydrophobic (about 90°), this may also impact the differences in cell adherence when 
comparing between PDLLA, glass coverslip and PCL controls (much more hydrophilic). 
More hydrophobic surfaces seemed to result in cells that were more flat, bipolar or 
tripolar in morphology, and also formed lamellipodia (actin projection on mobile edge), 
which is suggestive of high mobility and strong adhesion.
266
 This may be in part 
attributable to the rapid adsorption of proteins from the cell culture media onto the more 
hydrophobic surfaces, providing an ideal surface for cell adhesion. Stress fibers were also 
imaged on all surfaces, implying that cell growth and proliferation was successfully 
demonstrated and that actin cytoskeleton organization occurred. Actin stress fibres are 
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typically associated with strong focal adhesions, which could be tested via vinculin 
labeling (major protein associated with focal adhesions).  However, although cells were 
found to be more rounded on surfaces with slightly higher hydrophilicity, increasing the 
incubation time did result in increased cell elongation and therefore adhesion. Since 
C2C12 murine myoblast cells proliferate quickly (doubling in approximately 27 hours), 
some confocal images (such as Figure 3.29e) featured cells that displayed tips deeply 
stained by the dye, indicative of dynamic contact. Overall, actin filaments were observed 
on all tested surfaces. This linear polymer microfilament is important for cellular 
functions such as mobility and contraction of cells during division, thereby confirming 
the existence of healthy, proliferating cells. 
Quantitatively, unhealthy cell specimens would result in much fewer cells 
adhering to the substrate if conditions were unfavourable for proper attachment. Figure 
3.30 reveals the average density of cells on each surface, which ranged from 270-400 
cells/mm
2
. ANOVA tests confirmed that there were no significant differences between 
the results for the different surfaces. Control substrates such as glass are considered to be 
reasonably good substrates for cell growth, indicating that the graft copolymers provide 
favourable conditions as well. These results are crucial in determining cell adhesivity 
properties for potential implantable biomaterial applications. This importance is related to 
surgical implantation of different medical devices in that local tissue injury resulting from 
insertion of vascular grafts, heart valve sewing cuffs and annuloplasty rings, affects both 
thrombosis and inflammation at the site. Both of these processes are also known to 
contribute to healing of tissue into and around the device.
268
 Ensuring that a monolayer of 
endothelial cells can form on the surface of vascular grafts, for instance, can prevent 
thrombosis and allow for faster healing times.
108
  Moreover, this preliminary test also 
suggests that copolymers will provide a non-toxic environment, which will be confirmed 
via the MTT cytotoxicity assay. 
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Figure 3.30 – Cell adhesivity quantified by determining average cell concentrations 
for each substrate. 
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3.6.2 MTT Toxicity Assay 
Performing cytoxicity testing is also considered a pre-screening test; it is essential 
to carry out in order to quantify the number of cells that will remain viable upon 
incubation with potentially toxic biomaterial leachables. Fatal leachables may diffuse out 
of a material, thus causing a toxic environment, which is detrimental to cell proliferation. 
This test allowed for quantification of cell growth and differentiation associated with 
controls [glass, IIR, PCL, PDLLA and high density poly(ethylene)] and copolymers 3.14-
3.17. A slight adaptation of ISO 10993-5, ‘Biological Testing of Medical Devices – Part 
5: Tests for Cytoxicity, in vitro method, tests on extracts,’ was used as a quantitative 
means for determining cell viability. The ‘extract’ method was used in order to determine 
toxic effects that could possibly be generated by the biomaterials. In congruence with the 
American Society for Testing and Materials, approximately 80 mg of the material was 
used for each test. Melt-pressing the material into a uniform surface and cutting into 1 
cm
2
 pieces maintained surface area exposure for reproducible and reliable results. The 
culture media was used as an extracting medium at 37 °C for 24 hours prior to testing, as 
this allows sufficient time for possible leachables to enter the surrounding media. The 
cells were then incubated in serial two-fold dilutions of the leachate with fresh culture 
media. After 24 h incubation time with cells, a standard MTT cell viability assay was 
performed. In this case, a reduction of cell viability by more than 30% relative to control 
cells exposed only to fresh culture media is considered to be a toxic effect.  
The results of the MTT assay are shown in Figure 3.31. Positive and negative 
controls were included in each of the tests. High density poly(ethylene) (HDPE) was used 
as the negative control, as it does not elicit cytotoxic effects. Sodium lauryl sulfate (SDS) 
was used as a positive control to cause cell lysis, thereby compromising its integrity and 
health. Although PCL, PDLLA and IIR polymers are known to be biocompatible, 
investigating copolymer cytotoxicity and comparing between controls is highly relevant. 
As indicated in Figure 3.31, neither the negative control (HDPE) nor graft copolymers 
3.14-3.17 exhibit any significant cytotoxic effects. However, toxicity of SDS was 
confirmed at the expected concentrations of 0.2-0.10 mg/mL. 
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Figure 3.31 – MTT cytotoxicity assay performed on: a) graft copolymers 3.14-3.16; 
b) graft copolymer 3.17. 
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Chapter 4 
4 Materials and Methods 
4.1 General Procedures and Materials 
IIR 402 with a Mw of 395kDa and a polydispersity index (PDI) of 2.44, as measured by 
size exclusion chromatography (SEC), composed of 2.2mol% isoprene units was kindly 
provided by LANXESS and was converted to the activated derivative (3.13) by the 
previously reported method.
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 Hydroxy-terminated PCL (MW = 900 Da and 3500 Da) 
and PDLLA (MW = 2800Da) were purchased from Polymer Source (Montreal, Québec). 
Silicon wafers were purchased from University Wafer (Boston, Massachusetts). Cell 
culture materials were purchased from Nunclon and Invitrogen. Solvents were 
purchased from Caledon, PNPC was purchased from Alfa Aesar (used as received). m-
chloroperbenzoic acid was dissolved in toluene and dried with MgSO4 before use. 
Pyridine and ε-caprolactone monomer were distilled over CaH2 before use. All other 
chemicals were purchased from Sigma Aldrich and used without further purification 
unless stated otherwise. Dry dichloromethane and toluene were obtained from an 
Innovative Technology (Newburyport, USA) solvent purification system based on 
aluminum oxide columns. 
1
H NMR spectra were obtained in CDCl3 at 600 MHz using 
Varian Inova spectrometers. NMR chemical shifts are reported in ppm and are calibrated 
against residual solvent signals of CDCl3 (δ 7.26). Coupling constants (J) are reported in 
Hz. The percentage of functionalized isoprene units was determined from 
1
H NMR, 
based on the relative integrations of the signals at 5.03 and 4.87 ppm coinciding to the 
alkene adjacent to the activated carbonate and the PCL/PDLLA carbamate product, 
respectively. The PCL and PDLLA content in weight percentage was determined by 
1
H 
NMR, based on the relative integrations between the peaks at 4.03ppm (PCL methylene), 
5.19ppm (PDLLA methane) and 1.12ppm (isobutylene). Differential 
scanning calorimetry (DSC) was performed under a nitrogen atmosphere on a Q20 DSC 
TA instrument at a heating/cooling rate of 10 °C/min from -100 to + 100 °C. The Tg and 
Tm were obtained from the second heating cycle. SEC was performed in tetrahydrofuran 
(THF) using a Viscotek GPCmax VE 2001 GPC Solvent/Sample Module equipped with a 
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Waters 2489 UV/Visible Detector, Viscotek VE 3580 RI Detector and two PolyPore (300 
mm x 7.5 mm) columns from Agilent. The calibration was performed using polystyrene 
standards. FTIR was performed on a Bruker Optics TENSOR 27 series FT-IR, OPUS 7.0, 
via transmittance (%) with a background scan of 16 and a sample scan of 128, recording 
wavenumbers from 500-3700cm
-1
. 
4.2 Graft Copolymer Synthesis and Chemical 
Characterization 
4.2.1 Synthesis of Polymer 3.8a 
Following a previously reported literature,
148
 a round-bottom flask equipped with stir bar 
was charged with PCL homopolymer of 900 g/mol (3.7a) (0.40 g, 0.44 mmol, 1.0 equiv.), 
4-(dimethylamino)pyridine (DMAP) (0.20 g, 1.64 mmol, 3.7 equiv.) pyridine (0.10 g, 
1.29 mmol, 2.9 equiv.) and dichloromethane (DCM) (7 mL) under dry conditions. BOC-
protected β-alanine anhydride (3.6) (0.39 g, 1.1 mmol, 2.5 equiv.) was charged into a 
separate flask and dissolved in DCM (2 mL) under dry conditions. The latter solution was 
added to the PCL-containing solution and stirred overnight at room temperature. Next, 
deionized water was added to the reaction mixture and stirred for an additional 3 hours at 
room temperature. Purification involved washing with 1M HCl (3X), 1M Na2CO3 (3X) 
and concentrated brine (1X), followed by drying with MgSO4 and reduced pressure 
solvent removal.  
Yield: 0.35 g, 83% 
1
H NMR: δ, 4.24 (t, 2H, J = 4.7 Hz), 4.04-4.10 (m, 18H), 3.70 
(t, 2H, J = 5.1 Hz), 3.63-3.66 (m, 2H), 3.54-3.56 (m, 2H), 3.40 (br. s, 2H) 3.39 (s, 3H), 
2.51 (t, 2H, J = 6.1 Hz), 2.29-2.37 (m, 16H), 1.60-1.69 (m, 32H), 1.43 (s, 9H), 1.34-1.42 
(m, 16H). SEC: Mw = 3160 g/mol, PDI = 1.33. IR: 1047, 1105, 1171, 1246, 1366, 1420, 
1472, 1569, 1728, 2947, 2866, 3393, 3439 cm
-1
. 
Polymer 3.8b was prepared using the same procedure as described for polymer 3.8a, 
expect that PCL homopolymer of 3500 g/mol (3.7b) (0.40 g, 0.114 mmol, 1.0 equiv.) was 
used. 
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 Yield: 0.38 g, 88% 
1
H NMR: δ, 4.13 (td, 2H, J = 7.8, 4.7 Hz), 4.06 (t, 62H, J = 6.8 
Hz), 3.39 (q, 2H, J = 6.1 Hz), 2.51 (t, 2H, J = 6.1 Hz), 2.3 (t, 62H, J = 7.4 Hz), 1.62-1.68 
(m, 124H), 1.43 (s, 9H), 1.34-1.42 (m, 62H), 1.25 (t, 3H, J = 7 Hz). SEC: Mw = 9202 
g/mol, PDI = 1.22. IR: 1047, 1105, 1171, 1246, 1366, 1420, 1472, 1569, 1728, 2947, 
2866, 3393, 3439 cm
-1
. 
Polymer 3.11 was prepared using the same procedure as described for polymer 3.8a, 
expect that PDLLA homopolymer of 2800 g/mol (3.10) (0.40 g, 0.143 mmol, 1.0 equiv.) 
was used.  
 Yield: 0.31 g, 81% 
1
H NMR: δ, 5.12-5.25 (m, 39H), 4.23-4.32 (m, 2H), 3.57 (m, 
2H), 3.42 (br. s, 2H), 3.36 (s, 3H), 2.59 (m, 2H), 1.54-1.59 (m, 117H), 1.43 (s, 9H). SEC: 
Mw = 5098 g/mol, PDI = 1.19. IR: 1134, 1267, 1512, 1757, 2949, 2997, 3517, 3435 cm
-1
. 
4.2.2 Synthesis of Polymer 3.9a 
Polymer 3.8a (0.34 g, 0.373 mmol, 1.0 equiv.) was dissolved in 1.25 mL DCM: 1.25 mL 
trifluoroacetic acid (TFA) (1:1) and the reaction mixture was stirred for 2 hours. DCM 
and TFA were removed by pressurized air. The product was redissolved in DCM and 
dried in vacuo.  
Yield: 0.34 g, > 99% 
1
H NMR: δ, 4.24 (t, 2H, J = 4.7 Hz), 4.16 (t, 2H, J = 6.4 
Hz), 4.06 (t, 16H, J = 6.6 Hz), 3.7 (t, 2H, J = 4.7 Hz), 3.64-3.66 (m, 2H), 3.55-3.58 (m, 
2H), 3.39 (s, 3H), 3.33 (br. s, 2H), 2.8 (t, 2H, J = 5.9 Hz), 2.29-2.34 (m, 16H), 1.60-1.69 
(m, 32H), 1.34-1.42 (m, 16H). SEC: Mw = 2450 g/mol, PDI = 1.45. IR: 1047, 1105, 1171, 
1246, 1366, 1420, 1472, 1569, 1728, 2947, 2866, 3445 cm
-1
. 
Polymer 3.9b was prepared using the same procedure as described for polymer 3.9a, 
expect that polymer 3.8b (0.40 g, 0.114 mmol, 1.0 equiv.) was used. 
 Yield: 0.40 g, > 99% 
1
H NMR: δ, 4.17 (t, 2H, J = 6.5 Hz), 4.10-4.15 (m, 2H), 
4.06 (t, 62H, J = 6.5 Hz), 3.33 (t, 2H, J = 5.9 Hz), 2.83 (t, 2H, J = 5.3 Hz), 2.31 (t, 62H, J 
= 7.6 Hz), 1.62-1.68 (m, 124H), 1.36-1.41 (m, 62H), 1.25 (t, 3H, J = 7.6 Hz). SEC: Mw = 
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9030 g/mol, PDI = 1.22. IR: 1047, 1105, 1171, 1246, 1366, 1420, 1472, 1569, 1728, 
2947, 2866, 3445 cm
-1
. 
4.2.3 Synthesis of Polymer 3.12 
Polymer 3.11 and 2 mL of DCM were charged in a round-bottom flask equipped with stir 
bar under dry conditions. TFA was added (0.70 g, 6.11 mmol, 100 equiv.) and stirred at 
0°C for 2 hours. Next, DCM and TFA were removed under low pressure (~20 mbar), re-
dissolved in DCM and passed over a K2CO3 plug to remove residual TFA.  
Yield: 0.65 g, 91% 
1
H NMR: δ, 5.13-5.23 (m, 39H), 4.23-4.32 (m, 2H), 3.57 (tt, 
2H, J = 2.35, 3.52Hz), 3.36 (s, 3H), 3.29 (br. s, 2H), 2.83 (br. s, 2H), 1.54-1.58 (m, 
117H). SEC: Mw = 4740 g/mol, PDI = 1.31. IR: 1134, 1267, 1512, 1757, 2949, 2997, 
3508 cm
-1
. 
4.2.4 Synthesis of Graft Copolymer 3.14 
In a round-bottom flask equipped with stir bar, 3.9a (0.95 g, 1.06 mmol, 1.2 equiv.) was 
dissolved in 20mL of dry toluene at 60°C. A solution of PNPC-activated IIR (3.13)
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(2.19g, 0.882mmol of 4-nitrophenylcarbonate units, 1.0 equiv.) in 25mL of dry toluene 
was added dropwise to the reaction mixture. DMAP (0.43g, 3.52mmol, 4.0 equiv.) 
dissolved in 4mL dry toluene was also added to the reaction mixture, which was then 
stirred overnight at 60°C. The solvent was removed in vacuo and the graft copolymer was 
redissolved in DCM, washed with deionized water (3X), dried with MgSO4, concentrated 
and precipitated from DCM into acetone to afford copolymer 3.14.  
Yield: 2.45 g, 85% 
1
H NMR: δ, 5.20 (br. s, 1H), 5.10 (s, 1H), 5.05 (s, 1H), 4.87 
(s, 1H), 4.24 (t, 2H, J = 5.3 Hz), 4.06 (t, 16H, J = 6.5 Hz, 3.7 (t, 2H, J = 4.7 Hz), 3.6-3.65 
(m, 2H), 3.54-3.56 (m, 2H), 3.45 (q, 2H, J = 5.9 Hz), 3.38 (s, 3H), 2.53 (t, 2H, J = 6.2 
Hz), 2.3 (t, 16H, J = 7.6 Hz), 1.62-1.68 (m, 32H), 1.41 (s, 88H), 1.37-1.39 (m, 16H), 1.11 
(s, 264H). PCL content from 
1
H NMR = 15 wt%. DSC: Tg = -67°C. IR: 1165, 1230, 
1366, 1390, 1470, 1736, 2955, 3445 cm
-1
. 
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Graft copolymer 3.15 was prepared using the same procedure as described for polymer 
3.14, expect that polymer 3.9b (1.02 g, 0.292 mmol, 0.8 equiv. relative to 4-
nitrophenylcarbonate units) was used. 
 Yield: 1.17 g, 70% with a conversion of 50% (based on proton integrations 
corresponding to a and a’ (Figure 3.5). 1H NMR: δ, 8.27 (d, 1.5H, J = 9.1 Hz), 7.38 (d, 
1.5H, J = 9.1 Hz), 5.27 (s, 0.50H), 5.20 (br. s, 0.50H), 5.12 (s, 0.50H), 5.10 (s, 0.50H), 
5.05 (s, 0.50H), 4.87 (s, 0.50H), 4.13 (q, 2H, J = 7.2 Hz), 4.07 (t, 62H, J = 6.5 Hz), 3.45 
(q, 2H J = 5.9 Hz), 2.53 (t, 2H, J = 5.9 Hz), 2.31 (t, 62H, J = 7.3 Hz), 1.62-1.68 (m, 
124H), 1.41 (s, 88H), 1.36-1.40 (m, 62H), 1.25 (t, 3H, J = 7.3 Hz), 1.11 (s, 264H). PCL 
content from 
1
H NMR = 32 wt%. DSC: Tg = -65°C, Tm = 44°C. IR: 1165, 1230, 1366, 
1390, 1470, 1736, 2955, 3445 cm
-1
. 
Graft copolymer 3.16 was prepared using the same procedure as described for polymer 
3.14, expect that polymer 3.9b (0.34 g, 0.2098 mmol, 1.2 equiv. relative to 4-
nitrophenylcarbonate units) was used. 
Yield: 0.18 g, 75% 
1H NMR: δ, 5.19 (br. s, 1H), 5.1 (s, 1H), 5.05 (br. s, 1H), 4.87 
(br. s, 1H), 4.13 (q, 2H, J = 7.2 Hz), 4.07 (t, 62H, J = 6.5 Hz), 3.46 (q, 2H, J = 5.9 Hz), 
2.53 (t, 2H, J = 5.9 Hz), 2.31 (t, 62H, J = 7.3 Hz), 1.62-1.68 (m, 124H), 1.41 (s, 88H), 
1.36-1.40 (m, 62H), 1.25 (t, 3H, J = 7.3 Hz), 1.11 (s, 264H). PCL content from 
1
H NMR 
= 44 wt%. DSC: Tg = -62°C, Tm = 50°C. IR: 1165, 1230, 1366, 1390, 1470, 1736, 2955, 
3445 cm
-1
. 
Graft copolymer 3.17 was prepared using the same procedure as described for polymer 
3.14, expect that polymer 3.12 (0.65 g, 0.231 mmol, 1.2 equiv. relative to 4-
nitrophenylcarbonate units) was used. 
Yield: 0.51 g, 86% 
1
H NMR: δ, 5.14-5.25 (m, 39H), 5.11 (br. s, 1H), 5.04 (br. s, 
1H), 4.86 (s, 1H), 4.23-4.32 (m, 2H), 3.57-3.59 (m, 2H), 3.45-3.50 (m, 2H), 3.36 (s, 3H), 
2.61 (t, 2H, J = 2Hz), 1.54-1.59 (m, 117H), 1.41 (s, 88H), 1.11 (s, 264H). PDLLA 
content from 
1
H NMR = 46 wt%. DSC: Tg,1 = -63°C; Tg,2 = 23°C. SEC: Mw = 485 kDa, 
PDI = 3.81. IR:  1094, 1132, 1188, 1365, 1388, 1468, 1757, 2896, 2952 cm
-1
.  
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4.3 Physical Characterization 
4.3.1 Atomic Force Microscopy 
Silicon wafers were cut into small pieces (~1cm
2) and treated with “Piranha” solution, a 
mixture of 3:1 H2SO2:H2O2 for approximately 1 hour to generate a clean, hydrophilic 
oxide surface. The surface was then cleaned with deionized water, acetone and 
subsequently dried overnight in a desiccator. Polymer thin films were prepared by spin-
casting 100 μL of a 3 wt% solution of the material in toluene on 1 cm2 of silicon wafer at 
6000 rpm for 30 seconds. The surfaces were kept under vacuum for at least 24 hours 
prior to image analysis. Surfaces were visualized by an atomic force microscope (XE-100 
microscope from psia). Images were obtained by scanning surfaces in tapping mode with 
rectangular-shaped silicon cantilevers with a spring constant of 48 N/m. Images were 
then refined using XEI Image Processing software for SPM data by applying surface 
smoothing and glitch removal.  
4.3.2 Water Contact Angle 
The water contact angle of the polymer film surface in air was measured by using a 
sessile drop method on a KRÜSS DSA100 Drop Shape Analysis System (Hamburg, 
Germany). Timing started after dosing a water droplet onto the testing surface, allowing 
for an incubation period of 30 seconds for consistency. After 30 seconds, angles were 
recorded via tangent analysis. 
4.3.3 Scanning Electron Microscopy 
SEM micrographs were obtained using a Hitachi 3400-N Variable Pressure Scanning 
Electron Microscope. Images were taken at 100X and 1000X magnification utilizing 
variable pressure mode to avoid sample preparation via gold sputtering techniques 
(possible damage to rubber films).  
4.3.4 Mechanical Testing of Graft Copolymers 
A 40 mm x 5 mm x 0.3 mm (length x width x thickness) strip of polymer was cut from a 
polymer film (prepared via compression-molding with Carver Model 385-OC heated 
manual press) and its mechanical properties were measured on an INSTRON universal 
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testing machine 3300 series, at 25 mm/min and 25°C, in accordance with ASTM D882 – 
12. For each copolymer, at least 6 samples were tested in separate analyses, and the data 
reported is the calculated means. 
4.3.5 Degradation Study 
4.3.5.1 Preparation 
Graft copolymers and control materials were compression-moulded using a Carver Model 
385-OC (Carver Inc., Wabash) heated manual press into films approximately 0.35 mm in 
thickness. Disks were punched out of the films with a diameter of 5mm, producing a 
mass of approximately 5 mg per disk.  
4.3.5.2 Procedure 
The degradation was performed over a 4-month time period. 3 discs were measured at 
each time point to obtain an average of 3 measurements. Samples were immersed in 1 mL 
of 5M NaOH at 37°C in sealed vials and on completion of each time point, each sample 
was rinsed with deionized water and placed in a vacuum oven at 37°C for 24 h. Lastly, 
dried samples were weighed to determine % mass loss (as per Equation 9), analyzed by 
size exclusion chromatography (SEC) and by scanning electron microscopy (SEM, 1 
month intervals). 
  
            
        
   
      
 
9)  
Equation 9 – Where    = average mass of initial 3 discs for a given time point and 
    = average mass of final 3 discs for a given time point. 
The mass loss percentage was determined by calculating the average change in mass and 
dividing this value by the initial average mass and multiplying by 100 for each sample at 
each time point. 
. 
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4.4 Biological Characterization 
4.4.1 Cell Growth on Polymer Films 
C2C12 mouse myoblast cells were maintained at 37
o
C and 5% CO2 in Dulbecco’s 
Modified Eagle Medium (DMEM, Invitrogen) supplemented with 10% fetal bovine 
serum (Invitrogen) and supplemented with 1% Glutamax (100) solution and 1% 
Penstrep (100). Microscope glass cover slips (circular, 10 mm diameter) were coated 
using a 30 mg/mL solution of the copolymers 2, 3, 4 and 5 in toluene by drop-casting (3 
coats of 60 μL). The surfaces were placed in the wells of a 24-well (1 mL working 
volume, NunclonMultidishes) plate and sterilized by submersion in 70% ethanol for 
approximately 30 minutes, aspirated, then left to dry under UV light for approximately 1 
hour. Next, the samples were conditioned overnight in Hank’s balanced salt solution 
(HBSS). The sterilized samples were seeded with 2000 cells/surface and incubated for 3 
hours to promote cell adhesion. Upon adhesion, 0.5 mL of cell culture media was added 
to each well. The 24-well plate was incubated for 48 hours; samples were first washed 
with pre-warmed 1X phosphate-buffered saline (PBS, pH 7.2) (Invitrogen) and 
subsequently fixed with 4% paraformaldehyde in 1X PBS. Samples were washed three 
times with 1X PBS and then treated with 0.5mL of acetone at -20
o
C for 5 minutes to 
permeabilize the membrane. Next, they were washed another 3 times with 1X PBS, 
stained with Alexa Fluor 568 phalloidin (20X dilution with 1X PBS, Invitrogen) for 15 
minutes; 4’-6-diamidino-2-phenylindole dyhydrocholoride (DAPI, 300nM, 500X dilution 
with 1X PBS, Invitrogen) was added directly to the surfaces for an additional 5 minutes.  
The samples were washed a final 3 times with 1X PBS, placed face up onto glass 
microscope slides, sealed with ProLong Gold Antifade Reagent (Invitrogen) and 
contained with coverslips (type 1). Confocal images were obtained using a confocal laser 
scanning microscope (LSM 510 Duo Vario, Carl Zeiss) using a 20x objective and 
excitation wavelengths of 405 (DAPI) and 578 nm (Alexa Fluor 568 phalloidin). Cells 
were counted using cellc12, MATLAB-based program. Statistical analyses (ANOVA 
followed by Tukey’s honestly significant difference (HSD) post hoc method when 
statistically significant) were performed using Prism software. 
113 
 
4.4.2 MTT Toxicity Assay 
C2C12 mouse myoblast cells were first resuspended by use of Gibco® Trypsin/ 
ethylenediaminetetraacetic acid (EDTA) (solution of 0.025% trypsin and 0.01% EDTA in 
phosphate buffered saline); a cell count was performed with a haemocytometer. Based on 
this count, cells were seeded in a Nunclon® 96-well U bottom transparent polystrol plate 
to obtain 10 000 cells/well in a volume of 100μL Dulbecco’s Modified Eagle Medium 
(Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen), 1% Glutamax 
(100) solution and 1% Penstrep (100) to columns labelled C1-C8, SDS, 1-4 and VC 
(vehicle control). 100μL of DMEM was introduced to the column labeled JM (just 
media). The 96-well plate was then placed in a 5% CO2 incubator at 37°C for 24 hours. 
Testing samples were melt-pressed (0.015") to obtain uniformity (and to provide more 
surface area for potentially toxic leachates) and cut into squares of 1cm x 1cm. Samples 
were then sterilized in 70% ethanol for approximately 30 minutes and subsequently dried 
for 2 hours under UV light. Afterwards, they were placed in Petri dishes; 2 mL of DMEM 
was added and the resulting Petri dishes were placed in a CO2 incubator at 37°C for 24 
hours. After 24 hours, anything that was water soluble would be leached out of the testing 
samples; DMEM that samples were subjected to was then acquired via syringe and 
passed through a filter (to prevent particles >200 nm). Next, growth media from the 
Nunclon® 96-well plate was aspirated. 1200 μL of the filtered DMEM testing sample 
was obtained; 100μL was placed in each C8 well (as depicted in Table 4.1) to obtain a 
100% leachate testing column. 600 μL of fresh DMEM was then added to the remaining 
600 μL of filtered DMEM testing sample to create a 50% leachate; 100 μL was then 
added to each of the wells labeled C7. This process was repeated until C1 was reached 
with a 0.78% leachate dilution was attained. As a positive control to confirm cell death, 
sodium lauryl sulfate (SDS) was added to the columns labeled SDS1, SDS2, SDS3 and 
SDS4 with SDS concentrations in DMEM of 0.2 mg/mL, 0.15 mg/mL, 0.10 mg/mL and 
0.05mg/mL, respectively. Lastly, the columns labeled VC and media (M) had fresh 
DMEM introduced. The Nunclon® 96-well plate was then returned to a 5% CO2 
incubator at 37°C for 24 hours. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-
Diphenyltetrazolium Bromide) reagent was prepared at 5mg/mL in deionized water; 1 
mL of this solution was added to 10 mL of DMEM. Media was aspirated from the 96-
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well plate and replaced with 110 μL of the prepared MTT solution. The 96-well plate was 
returned to the incubator for an additional 4 hours. Lastly, the MTT solution was 
aspirated and replaced with 50 μL of spectroscopy grade dimethyl sulfoxide (DMSO) to 
solubilize reacted product crystals. The plate was subjected to M1000-Pro (plate reader) 
using Tecan i-control software at a wavelength of 540 nm. Samples were shook linearly 
for 1 s with amplitude of 2 mm and a frequency of 654 rpm prior to 25 flashes.  
Table 4.1 – Modified protocol adapted from ISO 10993 Technical Committee. 
(2007). International Organization for Standardization (ISO) 
SDS3 b  b  b  b  b  b  b  b  b  b  SDS1 
SDS3 M  C1  C2  C3  C4  C5  C6  C7  C8  VC  SDS1 
SDS3 M  C1  C2  C3  C4  C5  C6  C7  C8  VC  SDS1 
SDS3 M  C1  C2  C3  C4  C5  C6  C7  C8  VC  SDS1 
SDS4 M  C1  C2  C3  C4  C5  C6  C7  C8  VC  SDS2 
SDS4  M  C1  C2  C3  C4  C5  C6  C7  C8  VC  SDS2 
SDS4 M  C1  C2  C3  C4  C5  C6  C7  C8  VC  SDS2 
SDS4 b  b  b  b  b  b  b  b  b  b  SDS2 
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Chapter 5 
5 Conclusions and Future Work 
IIR is currently used for a variety of applications ranging from foodstuffs (chewing gum), 
bladders of sporting goods and most notably, as the innerliner for automotive tires. 
However, in recent years there has been significant interest in expanding its application in 
biomedical areas. Because of IIRs high elasticity and low strength, it has the inherent 
ability to mimic various soft tissues in the body. However, in order to use it in such 
applications as vascular prosthetics or orthopaedic implants, its properties have to be 
tuned in order to ensure the maintenance of its structural integrity. Therefore this thesis 
focused on synthesizing IIR-aliphatic polyester graft copolymers in order to tune IIR’s 
chemical, physical and biological properties. 
First, copolymer synthesis involving a “grafting-from” approach was investigated. 
Performing the ROP of PCL from hydroxyl moieties on the IIR backbone proved to be 
problematic and irreproducible. Therefore, the “grafting-to” method involving 
functionalization of both the IIR backbone as well as PCL and PDLLA homopolymers 
resulted in near 100% functionalization of IP units under mild conditions. Upon 
successful synthesis of copolymers, they were chemically (
1
H NMR, SEC, DSC and 
FTIR), physically (AFM, WCA, strain-controlled fatigue testing and accelerated 
degradability) and biologically (cell growth on polymer films and cytoxicity testing) 
characterized. 
By studying the aforementioned characterization data, some important property 
changes were imparted by grafting PCL or PDLLA to the IIR backbone. First, changes in 
thermal properties upon copolymer preparation suggested that physical properties may be 
altered. In fact, by increasing PCL/PDLLA wt%, it was found to induce phase separation, 
which was confirmed via AFM analysis. By increasing the percentage of PCL from 32 
wt% (copolymer 3.15) to 44 wt% (copolymer 3.16), properties were significantly altered, 
as uniaxial tensile testing results showed a dramatic increase in copolymer strength. In 
addition, IIR-PDLLA graft copolymer 3.17 (30 wt% PDLLA) also exhibited a 
comparative (IIR) increase in UTS. The grafting of these aliphatic polyesters appeared to 
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provide physical crosslinks, thereby increasing their strength while still maintaining 
compliance and structural integrity. These properties are especially important for 
applications involving implantable biomaterials. In addition, grafting of polyesters may 
supply ‘green strength,’ which is a measure of mechanical performance prior to 
vulcanization, which is associated with harsh chemical conditions.  
Copolymers consisting of lower PCL contents (copolymers 3.14 and 3.15) were 
interesting in terms of increased degradability that resulted from decreased levels of 
crystallinity. Long-term implantable devices that do not degrade at all elicit inflammation 
due to incompatibilities with the biological host. Perhaps such limitations could be 
remedied for extended-period applications through prolonged degradation and subsequent 
excretion of PCL from the body. In addition, imparting degradability to oxidatively, 
hydrolytically and enzymatically stable IIR may provide an avenue toward synthesis of 
environmentally friendly applications.  
Overall, this thesis provides an important contribution, establishing the 
groundwork for understanding the properties of IIR-PCL/PDLLA graft copolymers. 
Thorough analysis of chemical structure and its relation to property modification has led 
to the discovery of materials with potential for usage outside the breadth of typical IIR-
based applications. Future in vivo and rheological studies will be used to elucidate their 
biocompatibility and mechanical properties, respectively. These aspects require critical 
analysis before copolymers can be successfully employed in biomedical applications.      
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Appendices 
 
Appendix A – 1H NMR depicting functionalization of 3.7b: a) initial homopolymer; 
b) reacted with t-BOC-protected β-alanine (3.8b); c) and deprotected with TFA 
(3.9b). 
129 
 
 
Appendix B – 1H NMR showing PCL content of: a) copolymer 3.16 (44 wt% PCL) 
and b) copolymer 3.15 (32wt% PCL). 
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Appendix C – FTIR of: a) 3.8a and 3.9a; b) 3.11 and 3.12. 
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Appendix D – FTIR of: a) copolymer 3.14; b) copolymer 3.15. 
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Appendix E – FTIR of: a) copolymer 3.16; b) copolymer 3.17. 
133 
 
 
Appendix F – DSC traces of: IIR-PCL copolymer after 1st precipitation; IIR-PCL 
copolymer after a 2
nd
 precipitation into acetone, ridding of free homopolymer as 
evidenced by disappearance of the second Tm at 53°C. 
 
 
Appendix G – DSC trace depicting the two Tgs of copolymer 3.17. 
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Appendix H – DSC traces depicting Tg and Tm of IIR-PCL graft copolymers: a) 
copolymer 3.14; b) copolymer 3.15; c) copolymer 3.16. 
 
Appendix I – DSC traces depicting Tg and Tm of IIR-PCL/PLA blends. 
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Appendix J – Raw data coinciding with Figure 3.21 for the degradation study of 
IIR-PCL copolymers and IIR control. 
 
Appendix K – Raw data coinciding with Figure 3.22 for the degradation study of 
IIR-PDLLA copolymer and IIR control. 
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